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1Abstract
Nutrient availability and exercise training are two potent modulators of skeletal muscle 
adaptation. While the effects of nutrient provision or training alone on muscle adaptation have
been well researched, the interactive effects of these two stressors on whole-body metabolism 
and skeletal muscle adaptation are less well understood, especially in well-trained individuals. 
Furthermore, until recently, little work has been undertaken to determine some of the 
mechanisms that underlie the changes in muscle metabolism that result from the interaction of
nutrient and contractile status. Accordingly, the primary aims of the experiments undertaken for 
this thesis were: 1) to enhance our understanding of how skeletal muscle nutrient availability 
interacts with exercise training to promote changes in muscle and whole-body metabolism in 
well-trained athletes, and 2) to determine potential mechanisms that might underlie some of these 
adaptations. 
The first experiment (described in Chapter Three) was undertaken to determine the effects of a 
dietary periodisation strategy termed “fat adaptation and CHO restoration”, on subsequent 
changes in skeletal muscle fuel storage profile, whole-body metabolism and the potential 
mechanisms underlying these changes in well-trained humans. Utilising a randomised, crossover 
design, eight well-trained cyclists/triathletes underwent two 7-day trials separated by a 2-wk 
washout period. The interventions consisted of prescribed supervised endurance training while 
consuming either a high-fat diet for 5-days (4.6 g/kg/day fat, 68% of energy) followed by 1-day 
of high CHO restoration (FAT-adapt) or an isoenergetic high CHO diet for 6-days (HCHO; 10.3 
g/kg/day and 70% of energy). Muscle samples (~100-150 mg) were taken from the vastus 
lateralis at rest and after 60-min steady state cycling at 70% VO2peak (60SS) undertaken on day-7 
2of each intervention. Resting muscle glycogen content was not different between treatments 
(HCHO, 694 ± 55 vs. FAT-adapt, 547 ± 40 μmol/g dry wt.), but muscle triglyceride (TG) levels 
were higher after FAT-adapt (69 ± 10.2 vs. 39 ± 3.4 μmol/g dry wt.; P < 0.01). Resting 5’ AMP-
activated protein kinase (AMPK) -α1 and -α2 activity were higher after FAT-adapt (P < 0.05), 
while the phosphorylation of AMPK’s downstream target, acetyl-CoA carboxylase (pACC at 
Ser221), tended to be elevated after FAT-adapt (P = 0.09). Both the respiratory exchange ratio 
(RER; 0.87 ± 0.004 vs. 0.93 ± 0.004; P < 0.01) and muscle glycogen utilisation (179 ± 35 vs. 264 
± 45 μmol/g dry wt., P < 0.05) were lower during exercise after FAT-adapt. Exercise (60SS) 
increased AMPK-α1 activity after HCHO (P < 0.05) but not FAT-adapt. Exercise was associated 
with an increase in pACC at Ser221 for both dietary treatments (P < 0.05), with post exercise 
pACC Ser221 higher after FAT-adapt (P < 0.05). Resting muscle glycogen concentration was 
associated with AMPK-α1 activity (r = -0.51; P < 0.05) while resting muscle TG concentration 
was related to AMPK-α2 activity (r = 0.53; P < 0.05). In conclusion, compared with HCHO, 
FAT-adapt increased resting muscle TG stores and resting AMPK-α1 and -α2 activity. FAT-
adapt also resulted in higher rates of whole-body fat oxidation, reduced muscle glycogenolysis, 
and attenuated the exercise-induced rise in AMPK-α1 and AMPK-α2 activity compared with 
HCHO. These results demonstrate that AMPK-α1 and AMPK-α2 activity and fuel selection in 
skeletal muscle in response to exercise can be manipulated by diet and/or the interactive effects 
of diet and exercise training.
The second experiment described in Chapter Four was undertaken to determine the effects of a 
cycle training programme in which selected training sessions (50%) were commenced with low 
muscle glycogen content on training capacity and subsequent endurance performance, rates of 
3whole-body substrate oxidation during submaximal exercise, and several mitochondrial enzymes 
and signalling proteins associated with training adaptation. Seven endurance-trained 
cyclists/triathletes trained daily (HIGH) alternating between 100-min steady-state aerobic rides 
(AT) one day, followed by a high-intensity interval training session (HIT; 8 x 5 min at maximum 
self-selected effort) the next day. Another seven subjects matched for age, peak oxygen 
consumption (VO2peak) and training history trained twice every second day (LOW), first 
undertaking AT, then 1–2 hr later, the HIT. Training power output (W) was monitored during 
each session and the respective training schedules were maintained for 3-wk. Forty-eight hours 
before and after the first and last training session, all subjects completed a 60SS followed by a 
60-min performance trial. Muscle biopsies were taken before and after 60SS, with rates of 
substrate oxidation determined at regular intervals throughout this ride. Performance was 
determined as the highest average power output (W) maintained during the ride. Resting muscle 
glycogen concentration (412 ± 51 vs. 577 ± 34 μmol/g dry wt.), rates of whole body fat oxidation 
during 60SS (1,261 ± 247 vs. 1,698 ± 174 μmol/kg/60 min), the maximal activities of citrate 
synthase (45 ± 2 vs. 54 ± 1 mmol/kg dry wt./min), and β-hydroxyacyl-CoA dehydrogenase (18 ±
2 vs. 23 ± 2 mmol/kg dry wt./min) along with the total protein content of cytochrome c oxidase 
subunit IV were increased only in LOW after the 3-wk intervention (all P < 0.05). Mitochondrial 
DNA content and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) protein 
levels were unchanged for both groups after training. Self-selected training intensity was lower in 
week 1 (P < 0.05) and tended to be lower in week 2 (P = 0.06) in LOW, but was not different for
both groups in week 3. Cycling performance improved by ~ 10% in both LOW and HIGH. It is 
concluded that compared with training daily, training twice every second day compromised high-
intensity training capacity. While selected muscle markers of training adaptation were enhanced 
4with twice-a-day training, the performance of a 1-hr time trial undertaken after a 60-min steady-
state ride was similar after once daily or twice every second day training programmes.
The final experiment in this thesis (Chapter Five) was undertaken in an attempt to elucidate 
potential mechanisms underlying the enhanced training adaptations observed after performing 
selected training sessions with low muscle glycogen concentration. Six endurance-trained 
cyclists/triathletes performed an AT on day-1 and HIT 24 h later (HIGH). Another six subjects 
matched for age, VO2peak and training history performed AT on day 1 then 1-2 h later, HIT 
(LOW). Muscle biopsies were taken before and after HIT. AMPK phosphorylation increased in 
both groups after HIT (P < 0.05) but to a greater extent in LOW compared with HIGH (P < 0.05). 
Despite the augmented AMPK response in LOW after HIT, the localisation and phosphorylation 
state of selected AMPK downstream substrates were not different between groups. 
Phosphorylation of p38 MAPK was unchanged for both groups before and after HIT sessions. 
Phosphorylation of CAMKII-βm isoform was similar before HIT in both groups but increased 
significantly only in HIGH after HIT. There were no effects of treatment or time on the 
phosphorylation of CAMKII-δ/γ isoform or when all three of the CAMKII isoforms were 
quantified collectively. Taken collectively, these results suggested that AMPK was 
phosphorylated to a greater extent when performing HIT sessions with low muscle glycogen 
concentration and the enhanced adaptations seen in the previous study (Chapter Four) were likely 
to be mediated by AMPK and/or other unidentified downstream targets.
In summary, the results of the studies undertaken for this thesis provide novel insights into the 
mechanisms by which the manipulation of nutrient availability and subsequent muscle fuel 
5storage profile interact with endurance exercise training to promote changes in skeletal muscle 
metabolism and adaptation in well-trained athletes. A dietary periodisation strategy consisting 
of fat adaptation and CHO restoration was shown to increase resting muscle TG and glycogen 
content, with these changes in fuel stores being associated with an isoform specific activation 
of AMPK. The increase in AMPK activity after fat adaptation, coupled with the increased 
phosphorylation status of AMPKs downstream target, ACC, provides evidence of a mechanistic 
link between muscle nutrient availability and the subsequent metabolic responses. However, 
while it is tempting to attribute a causal role for altered muscle substrate availability (i.e. 
glycogen and/or triglyceride stores) on subsequent changes in AMPK signalling, it should be 
acknowledged that differences in AMPK responses could also be due to the well-trained 
subjects performing prolonged, strenuous training on a high-fat diet (i.e., the interactive effects 
of diet and exercise). To further investigate the links between muscle fuel stores and training 
adaptation, well-trained subjects undertook a chronic (3-wk) intervention in which they 
commenced ~50% their training sessions with either normal or reduced muscle glycogen 
content. Selected markers of training adaptation were enhanced with twice-a-day versus daily 
training. Again, AMPK was elevated to a greater extent when subjects trained with low 
compared to normal glycogen content, although selected downstream targets were unaffected 
by either diet-training regimen. It would seem safe to conclude that the changes in AMPK 
activation observed in these studies could be due to altered fuel status (i.e., increased muscle 
lipid availability, reduced muscle glycogen content), a greater adaptive response when training 
with low muscle glycogen availability, or most likely, the interactive effects of both these 
factors.
6Chapter One
Literature Review
71.1 Nutritional intervention: performance versus training adaptation.
Nutrient availability has long been recognised as one of the most potent modulators of skeletal 
muscle adaptation. The manipulation of dietary macronutrient intake lasting as short as 2-5
days has been shown to have marked effects on substrate stores (Zderic, et al., 2004) and 
skeletal muscle gene expression (Arkinstall, et al., 2004; Cameron-Smith, et al., 2003; Jump 
and Clarke, 1999). This in turn affects not only resting energy metabolism, but also metabolic
flux and fuel utilisation during subsequent exercise (Coyle, et al., 2001; Horowitz, et al., 1997; 
1999). While the effects of training and diet alone on skeletal muscle adaptation and exercise 
performance have been studied extensively, the interactive effects of diet and training on 
skeletal muscle adaptation have received less attention and the regulation of the cellular and 
molecular processes of adaptation to these two stimuli are largely unknown (Hawley, et al., 
2006).  
It is commonly accepted that adaptation to training requires optimal muscle nutrient reserves 
prior to and during recovery from training (Burke, et al., 2004; Hawley, et al., 2006; Jentjens, et 
al., 2003). In this regard, a high carbohydrate (CHO) diet (~80% of energy; >6g CHO/kg body 
mass) has been associated with elevated muscle and liver glycogen concentration and 
enhancement of subsequent exercise performance compared to a CHO restricted diet 
(Bergstrom, et al., 1967). Indeed, the current consensus is that a high CHO diet enables an 
athlete to train longer, harder and faster and thus achieves a superior training response 
compared to a diet low in CHO (Coyle, 2000; Hansen, et al., 2005; Hawley, et al., 2006). 
However this paradigm does not consider the long unsolved question of whether it is a lack or a 
surplus of a substrate (i.e. CHO) that triggers skeletal muscle adaptation in response to training 
8(Coyle, 2000; Hansen, et al., 2005; Hawley, et al., 2006). While the role of high CHO diet on 
metabolism and exercise capacity has been well researched, it is currently unknown if this 
dietary strategy provides a superior training stimulus for skeletal muscle adaptation compared 
to a diet low in CHO. Indeed, it has recently been shown that commencing exercise with low 
muscle glycogen concentration increases the transcription rate of several genes and proteins 
involved in the training response/adaptation (Febbraio, et al., 2002; Furuyama, et al., 2003; 
Keller, et al., 2001; Pilegaard, et al., 2002; Steinberg, et al., 2006; Wojtaszewski, et al., 2003). 
In rats and cell lines, raising plasma free fatty acid (FFA) levels activates several signalling
proteins involved in fatty acid oxidation (Garcia-Roves, et al., 2007) and mitochondrial 
biogenesis (Garcia-Roves, et al., 2007; Watt, et al., 2006), as well as increases the expression of 
genes encoding fatty acid oxidation enzymes and mitochondrial citrate cycle and respiratory 
chain enzymes (Garcia-Roves, et al., 2007). Furthermore, the increase in transcriptional
regulation of several metabolic genes after exercise was sustained/enhanced through 8-24 hr 
when subjects were given a low CHO diet while a high CHO diet reversed the activation of 
these genes in 5-8 hr after exercise (Pilegaard, et al., 2005).        
Recently, Baar & McGee (2008) postulated that the classic progressive overload principle for 
exercise training adaptation incorporating exercise frequency, intensity and duration is no longer 
adequate. They suggested that the “principle of optimal nutrition” needs to be incorporated into 
modern training programmes, and that training should be optimised by periodising nutrient intake 
according to the demands and needs of different phases of preparation. In support of this theory, 
Stellingwerff et al. (2007a) provide specific dietary intake recommendations to optimise training 
adaptation for different phases of training for middle-distance runners (Table 1.1). In accordance 
9to the demands and goals of different training phases, Stellingwerff et al., (2007a) recommended 
that the total energy intake and percentage of fat from total daily energy intake (%FAT) be 
reduced progressively from the general preparation phase through to the competition phase
(Table 1.1). In contrast, the percentage of CHO from total daily energy intake (%CHO) should
increase progressively from the general preparation phase through to the competition phase
(Table 1.1). It was recommended that during the transition phase, both %CHO and total daily 
energy intake be tapered while %FAT was recommended to be increased (Table 1.1).
However, ‘dietary periodisation’ is certainly not a new concept: the classical carbohydrate 
loading strategy of Bergstrom, et al. (1967) was probably the first attempt to manipulate 
exercise/nutrient intake to optimise muscle fuel stores and exercise performance. In addition, 
more than a decade ago, Hawley and Hopkins (1995) proposed that dietary periodisation should 
be utilised to optimise training stimuli and the authors (Hawley and Hopkins, 1995) suggested 
that both CHO and fat availability to be modified to enhance the aerobic glycolytic and lypolytic 
power systems respectively.
It is apparent that while the role of a high CHO diet in increasing muscle glycogen stores and 
enhancing endurance performance is firmly established, less is known regarding manipulating 
chronic CHO availability during training. In addition, apart form manipulating CHO availability,
there seems to be a possibility for fat to be used in conjunction with exercise training to modify 
training response (Hawley and Hopkins, 1995). Nevertheless, evidence to support this claim is 
still lacking and the mechanistic explanation for this nutrient-training interaction remains 
unknown.    
10
Table 1.1 Daily macronutrient intake recommendations for a 70-kg athlete during different yearly training phases.
Prep, preparation; R&R, rest and recovery; CHO, carbohydrate; PRO, protein; [reproduced from Stellingwerff et al. (2007a)].
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1.2 Overview: Endurance training and skeletal muscle adaptation
Exercise training is the most potent modulator of skeletal muscle adaptation. Performing a single 
bout of prolonged endurance exercise provides significant challenges to skeletal muscle
metabolic homeostasis. In sedentary individuals, an acute bout of submaximal exercise results in 
marked increases in the concentrations of adenosine monophosphate (AMP), inorganic phosphate 
and lactate while concomitantly decreasing the concentrations of adenosine triphosphate (ATP), 
creatine phosphate (PCr) and muscle substrate stores (i.e. glycogen and triglyceride). However, 
performing repeated bouts of endurance activity (i.e. exercise training) reduces these 
perturbations in metabolic homeostasis and subsequently enables individuals to perform exercise 
of a similar intensity for a longer period of time. 
It was initially thought that the increased capacity to perform submaximal prolonged endurance 
exercise was exclusively due to the cardiovascular adaptations to endurance training which allow
more oxygen (O2) to be delivered to working muscles (Holloszy and Coyle, 1984). Central to this 
premise was that the increased O2 supply resulting from the enhanced cardiorespiratory function 
would reduce the intramyocellular ‘hypoxic’ environment during subsequent muscular 
contractions to allow an individual to exercise at similar intensity for longer period of time
(Holloszy and Coyle, 1984). However, if this was the case, one would expect the O2 consumption 
during submaximal prolonged exercise at a similar absolute intensity to be higher after training. 
In contrast, it was reported that O2 consumption during submaximal exercise was the same in the 
trained and untrained states (Hagberg, et al., 1980; Hickson, et al., 1978). This observation has 
prompted exercise scientists to believe that the main mechanisms underlying the improved 
capacity to performed prolonged submaximal exercise observed after endurance training to reside
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in skeletal muscle, and in particular the mitochondria. Indeed, in his seminal work using rats,
Holloszy (1967) showed that endurance training is a powerful stimulator for mitochondrial 
adaptations in skeletal muscle. In that study (Holloszy, 1967), rats were subjected to three months 
of progressive endurance training where running speed and duration were gradually increased. 
Remarkably, Holloszy (1967) reported that submaximal running time to exhaustion was 
improved by over 600% (from ~30 min to ~190 min) after this training regimen. This enhanced 
endurance ability was also accompanied by substantial increases in mitochondrial enzymatic 
activities and protein concentrations and subsequently higher capacity of respiratory control and 
oxidative phosphorylation (Holloszy, 1967).  
These enhanced mitochondrial adaptations in response to endurance training (termed 
mitochondrial biogenesis), were later confirmed in humans by many investigators. Both cross-
sectional and longitudinal studies in humans revealed that well trained endurance athletes 
demonstrated higher mitochondrial volume density (Hoppeler, et al., 1973; Morgan, et al., 1971), 
and increased levels of mitochondrial enzymes involved not only in fatty acid transport (Costill, 
et al., 1979; Jong-Yeon, et al., 2002) and oxidation (Chi, et al., 1983; Costill, et al., 1979; Jansson 
and Kaijser, 1977; Schantz, et al., 1983), but also enzymes involved in the citrate cycle (Chi, et 
al., 1983; Gollnick, et al., 1972; Schantz, et al., 1983) and respiratory chain (Costill, et al., 1979; 
Gollnick, et al., 1973; Jansson and Kaijser, 1977; Morgan, et al., 1971). These enhanced 
mitochondrial and enzymatic adaptations subsequently resulted in an enhanced capacity to 
oxidise fatty acids (FA), thus permitting a greater reliance on fat to fuel oxidative metabolism
while concomitantly attenuating endogenous CHO utilisation (Holloszy and Coyle, 1984). Indeed,
one of the ‘classic’ adaptations to endurance training is a lower respiratory exchange ratio (RER), 
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indicating a shift from CHO- to fat-based fuels in both males (Brooks and Mercier, 1994; Hurley, 
et al., 1986; Martin, et al., 1993) and females (Stisen, et al., 2006). In addition, the mitochondrial 
enzyme β-hydroxyacyl-CoA dehydrogenase (β-HAD) has also been shown to be significantly 
correlated with the rate of whole-body fatty acid oxidation during moderate exercise (Stisen, et 
al., 2006). Furthermore, in human skeletal muscle, exercise training has been shown to increase 
rates of fat oxidation by ~24% and this was accompanied by a similar increased in FAT/CD36 
mRNA and protein content. Compared to untrained humans, endurance trained humans have 
been shown to utilise more muscle triglyceride (Helge, et al., 2006; Hurley, et al., 1986) while 
concomitantly reducing muscle glycogen utilisation (41% lower) during exercise (Hurley, et al., 
1986).
Taken collectively, these results indicated that endurance training is a powerful stimulator for 
mitochondrial biogenesis in human skeletal muscle. These increases in mitochondrial 
morphological and enzymatic adaptations confer an individual greater ability to utilised FA to 
fuel prolonged exercise. As a result, the depletion of muscle glycogen is delayed and the 
individual is able to perform similar endurance activity at similar absolute intensity for longer 
period of time after endurance training. 
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1.3 Nutrient-training strategies to enhance training response
While it is well known that endurance training promotes mitochondrial adaptations that result 
in marked increases in rates of whole-body fat oxidation, several dietary protocols are capable 
of promoting further changes in muscle function that augment the oxidation of lipid-based fuels 
(i.e. muscle TG and blood-borne lipids). These strategies are termed ‘nutrient-training’ 
strategies in this thesis because they involve the coupling of both nutrient availability and 
endurance training to promote the intended training response. In this regard, nutrient 
availability is often modified by either altering the dietary intake profile, or by changing the 
training schedule which subsequently result in changes in substrate storage profile with the aim 
of modifying the training stimulus. Chief among these strategies are fat adaptation with and 
without CHO restoration, training in the face of low muscle glycogen and commencing training 
in the ‘fasted’ state.
1.3.1 Fat adaptation
Background
While glycogen storage in human skeletal muscle and liver is limited, lipid storage in muscle and 
particularly adipose tissue is abundant, with absolute amounts being sufficient for many 
hours/days of continuous exercise even in the leanest of athletes (Burke and Hawley, 2002). 
Logically, one would assume that a training method that increases the rate of fat oxidation during 
exercise to a level beyond that which has already been achieved by training would enhance 
endurance capacity. Both acute and chronic modification of the fat and CHO content of the diet 
have been long known to result in altered proportions of substrate oxidation both at rest and 
during exercise (Burke and Hawley, 2002; Helge, 2000; Helge, 2002; Krogh and Lindhard, 1920). 
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One such dietary-training intervention termed “fat adaptation” is when an athlete consumes a 
high-fat, low-CHO diet while undertaking an endurance training programme in order to promote 
higher rates of fat utilisation during exercise (protocols to be discussed in subsequent section).
Fat feeding strategies have a long history and since the beginning of last century, studies have
been performed to investigate the role of dietary fat manipulation with an aim to link endurance 
performance and substrate oxidation (Helge, 2000). Helge (2000) reviewed a number of studies 
that investigate the effects of short- and long-term fat adaptation on metabolism and performance 
and concluded that while fat adaptation is able to improve substrate utilisation during exercise, 
performance is often attenuated, or in the best case scenario, maintained (Helge, 2000). However, 
since then, there have been several studies that have found a performance benefit of fat 
adaptation strategies in well-trained subjects, although these results are perhaps best explained by 
individuals who are ‘responders’ (i.e. who can benefit from fat adaptation strategies), while 
others are ‘non-responders’ (Table 1.2). Indeed, in a recent meta analysis to examine the effects
of high fat or high CHO diets on endurance performance, Erlenbusch et al., (2005) showed that
there are great differences in the effect sizes between trained and untrained humans in studies 
investigating high fat diets and performance, indicating that trained individuals possess the 
metabolic machinery to tolerate the effects of high fat diet better than the untrained. These 
authors (Erlenbusch, et al., 2005) suggested that trained subjects should be studied to increase the 
likelihood of a high fat effect on performance. Clearly, there appears to be a need to re-visit this 
topic of interest using well-trained subjects, and the potential mechanisms underlying the 
alterations in muscle metabolism that result from fat adaptation strategies. In the context of this 
thesis, such mechanistic links may provide an indication of the effects of fat-adaptation strategies 
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in modulating skeletal muscle adaptation in well-trained humans. The following section 
summarises the potential mechanisms that may underlie the adaptations seen with fat adaptation 
strategies in well-trained athletes.
Fat adaptation: potential mechanisms of action
Fat adaptation strategies dramatically increase whole body rates of fat oxidation and attenuate 
muscle glycogen utilisation during submaximal exercise in already well-trained athletes (Table 
1.2). These alterations in substrate metabolism during exercise are believed to be due to changes 
residing in skeletal muscle and involve processes associated with either, fat and CHO oxidation at 
the level of substrate transport at the sarcolemma, substrate storage, breakdown of FA’s or 
glucose to acetyl-CoA, or mitochondrial transport. In this regard, a primary means for transport 
of fatty acids into contracting skeletal muscle cells is via the fatty acid transporters FAT/CD36
and plasma membrane fatty acid binding protein (FABPpm). Five days of fat adaptation was 
shown to increase FAT/CD36 mRNA and protein content in well-trained subjects (Cameron-
Smith, et al., 2003; Table 1.2). Another fatty acid transporter across sarcolemma investigated in 
that study (Cameron-Smith, et al., 2003), FABPpm was however unchanged, suggesting that 
FAT/CD36 is more sensitive to changes in dietary fat content than the FABPpm and that the 
improved FA transport across sarcolemma through FAT/CD36 might be one of the mechanisms 
by which fat adaptation strategies increased fat oxidation during exercise.    
In the muscle cells, long chain FA’s first require transport into mitochondria before they can be 
further broken down prior to oxidation. This process requires transport via mitochondrial 
carnitine palmitoyltransferase 1 (CPT1). CPT1 activity was found to be increased after both 15 
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(Goedecke, et al., 1999) and 28 days (Fisher, et al., 1983) of fat adaptation, although a later study 
(Cameron-Smith, et al., 2003) found that the mRNA and protein abundance of CPT1 was 
unchanged after a shorter (5 days) intervention on a high fat diet (Table 1.2).
In order to increase the rates of whole-body fat oxidation during exercise, the increase in FA
transport across sarcolemma and the mitochondrial membrane should theoretically be coupled 
with an enhanced ability to oxidised fat. In this regard, liberated FA’s can enter the beta oxidation 
cycle to produce acetyl-CoA and the rate limiting enzyme for this process is the -hydrocyacyl-
CoA dehydrogenase (-HAD). The maximal activity of this rate limiting enzyme was shown to 
be elevated after 2-wk of fat adaptation (Goedecke, et al., 1999; Table 1.2). However, Fisher et al.
(Fisher, et al., 1983) demonstrated that hexokinase activity was reduced by 4 wk fat adaptation
(Table 1.2), suggesting that apart from increased fat oxidation ability, the ability to oxidise
glucose may actually be compromised by fat adaptation strategies.
Perhaps most importantly, fat adaptation strategies result in reduced muscle glycogen content, 
and regardless of the level to which fat oxidation is elevated during exercise, it is of utmost 
important for athletes to approach endurance sporting competitions with maximised glycogen 
storage (Burke, et al., 2004) as muscle glycogen content has long been associated with fatigue 
during exercise (Bergstrom, et al., 1967).
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1.3.2 Fat adaptation and CHO restoration
Background and protocols
To circumvent the issue of reduced glycogen storage as a result of high-fat diets, several groups
(Burke, et al., 2000; Burke, et al., 2002; Carey, et al., 2001; Lambert, et al., 2001; Rowlands and 
Hopkins, 2002; Stellingwerff, et al., 2006) have proposed that a ‘dietary periodisation’ model 
involving fat adaptation with CHO restoration would result in optimising both rates of fat 
oxidation while concomitantly maximising glycogen storage. In this model, a period of fat 
adaptation (~5-12 days, ~4.6 g/kg/day or ~70% energy from fat and ~15% energy from CHO) is
followed by a short term (1-3 days, ~15% energy from fat and ~10.3 g/kg/day or ~70% energy 
from CHO) CHO restoration phase (Figure 1.1). It was hypothesised that the short restoration 
phase (1-3 days) would be sufficient to restore glycogen, but at least part of the elevated fat 
oxidative response to fat adaptation would persist even in the face of higher glycogen content 
(Burke, et al., 2000). This was critical to the concept, since after a ‘standard’ high CHO diet, high 
starting muscle glycogen concentration coincides with a correspondingly high utilisation rate 
during exercise. Consequently physiological adaptations that allow an increased rate of fat 
oxidation and sparing of glycogen in spite of high starting glycogen content should in theory,
represent the ideal scenario for maximizing endurance capacity. 
In general, protocols that have utilised fat adaptation with CHO restoration have utilised a cross-
over design, whereby a “control diet” consisting of a high CHO diet (containing the same 
macronutrient and fibre composition as CHO restoration) is compared to the fat adaptation and 
CHO restoration diet (Figure 1.1). Subjects are also required to maintain their regular training 
programme, including high intensity training sessions, throughout the duration of the study. 
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Figure 1.1 Overview of the general experimental design for studies utilising the model of 
fat adaptation and carbohydrate restoration.
Interestingly, even though studies have used from 1-3 days to restore muscle (and liver) glycogen 
stores, it has been shown that only 1 day of CHO restoration is necessary to “top up” muscle 
glycogen concentration in endurance-trained athletes (Burke, et al., 2000; Stellingwerff, et al., 
2006). A consistent finding is that, while CHO restoration suppressed fat oxidation relative to the 
levels seen prior to restoration, rates of fat oxidation remain higher than prior to initiation of the 
fat adaptation phase (Burke, et al., 2000; Stellingwerff, et al., 2006). Even when CHO availability 
is increased acutely (by feeding a high CHO breakfast prior to, or ingesting CHO during
exercise), elevated rates of fat oxidation persist (Burke, et al., 2002; Carey, et al., 2001). It was 
also shown that the reduction in CHO oxidation observed during exercise after fat adaptation and 
CHO restoration strategies can be accounted for by the reduction in muscle glycogen utlisation 
during exercise, despite the fact that muscle glycogen was restored to a high level after the CHO 
restoration phase (Burke, et al., 2000; Lambert, et al., 2001; Table 1.2).
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Table 1.2     Summary of studies investigating fat adaptation with and without carbohydrate restoration in well-trained athletes 
Study Subjects Protocol FATox Skeletal muscle adaptation Performance
(vs. Cont) (vs. Cont) (vs. Cont)
Phinney et. al. n=5 male   One-week eucaloric balanced diet  ↑   3 fold ↓ in glucose oxidation;    Time to exhaustion ↔
1983 Well-trained cyclists (> 65 mL/kg/min)   followed by 4-week ketogenic diet   4 fold ↓ in glycogen utlization
Fisher et. al. n=5 male   One-week eucaloric balanced diet  ↑   ↓ glycogen content; ↓ glycogen utilzation   Time to exhaustion  ↔
1983 Well-trained cyclists (5.1 L/min)   followed by 4-week ketogenic diet   ↑ CPT & ↓ hexokinase activities   (60% VO2max)
Muoio et. al. n=6 male   Cont: Normal ↔   HFAT ↑ VO2max and 
1994 Well-trained runners (63.7 mL/kg/min)   Expt: HCHO ↔   running time to exhaustion
  Expt: HFAT ↔
Lambert et. al. n=5 male   Cont: 2 weeks HCHO   ↓ glycogen content (resting)   HFAT ↑ time to exhaustion
1994 Trained cyclists (4.2 L/min)   Expt: 2 weeks HFAT  ↑    (60% VO2max)
Goedecke et. al. n=16 male   Cont: Habitual   ↓ glycogen oxidation; ↑ CPT activities;   40km time trial (TT) ↔
1999 Trained cyclists (63.5 mL/kg/min)   Expt: HFAT  ↑   citrate synthase & β-HAD ↔
Burke et. al. n=8 male   Cont: 6-day HCHO   ↓ glycogen content after 5-day HFAT but   TT performance (7kj/kg) 
2000 Well-trained cyclists (64.4 mL/kg/min)   Expt: 5-day HFAT + 1-day HCHO  ↑   restored after 1-day HCHO; ↓ glycogen utlization   with 120 min preload ↔ 
Carey et. al. n=7 male   Cont: 7-day HCHO   60 min performance trial (km) 
2001 Well-trained cyclists (5.06 L/min)   Expt: 6-day HFAT + 1-day HCHO  ↑   with 4 hr preload ↔ 
Lambert et. al. n=5 male   Cont: 10-day habitual diet + 3-day HCHO   ↓ estimated rates of muscle glycogen &   ↑ 20-km TT performance
2001 Well-trained cyclists (4.9 L/min)   Expt: 10-day HFAT + 3-day HCHO  ↑   lactate oxidation   (with 150 min preload)
Rowlands & n=7 male   Cont: 14-day HCHO   HFAT & HFAT + CHO ↓ decline 
Hopkins 2002 Well-trained male (72 mL/kg/min)   Expt: 14-day HFAT  ↑   in power output during 100km TT
  Expt: 11.5-day HFAT + 2.5-day HCHO  ↑
Burke et. al. n=8 male   Cont: 6-day HCHO   Plasma glucose uptake ↔   TT performance (7kj/kg) 
2002 Well-trained cyclists (68.6 mL/kg/min)   Expt: 5-day HFAT + 1-day HCHO  ↑   with 120 min preload ↔ 
Cameron-Smith n=14 male   Cont: 5-day HCHO   HFAT ↑ FAT/CD36 (protein & mRNA)  
et. al. 2003 Well-trained male (67 mL/kg/min)   Expt: 5-day HFAT  ↑   & β-HAD mRNA 
Havemann et. al. n=8 male   Cont: 7-day HCHO   Normalized EMG amplitude during    ↓ 1-km sprint power output, 
2006 Well-trained (57.8 mL/kg/min)   Expt: 6-day HFAT + 1-day HCHO  ↑   1-km sprint ↔   TT performance (100km) ↔ 
Stellingwerff n=7 male   Cont: 6-day HCHO   ↓ PDH activity; ↓ glycogenolysis
et. al. 2006 Well-trained cyclists (60.7 mL/kg/min)   Expt: 5-day HFAT + 1-day HCHO  ↑   ↓ estimated substrate phosphorylation
↑, increase; ↓, decrease, ↔, unchanged; Cont, Control group; Expt, Experimental group; HCHO, High carbohydrate diet; HFAT, High fat diet.    
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Fat adaptation and carbohydrate restoration: potential mechanisms of action
A recent study by Stellingwerff et al. (2006) has provided a new insight into the mechanisms by 
which fat adaptation with or without CHO restoration modifies substrate metabolism during 
exercise. Utilising a five day fat adaptation followed by one day CHO restoration protocol and 
well-trained athletes as subjects, Stellingwerff et al., (2006) reported that pyruvate dehydrogenase 
(PDH) activity was 56% lower at rest and 29% lower after a 20-min submaximal cycle exercise 
after fat adaptation and CHO restoration intervention. Moreover, a reduced PDH activity was also 
demonstrated after a 1-min sprint cycle exercise following this dietary intervention (Stellingwerff, 
et al., 2006). Calculated rates of muscle glycogenolysis were significantly lower during the first 
minute of both the submaximal and sprint cycle exercise (9.1 ± 1.1 vs. 13.4 ± 2.1 and 37.3 ± 5.1 
vs. 50.5 ± 2.7 glucosyl units/kg/min dry wt. respectively) and estimated substrate 
phosphorylation was also lower during the first minute of the submaximal cycle exercise after fat 
adaptation and CHO restoration trial (Stellingwerff, et al., 2006). Collectively, these results 
indicated that the increased fat oxidation capacity observed after fat adaptation and CHO 
restoration may well be an artifact of a decrease in the ability to oxidise CHO (i.e. an impairment 
to CHO breakdown).
While the results of Stellingwerff et al. (2006) are intriguing, it is important to note that the actual 
metabolic signals that accounted for the shifts in substrate selection during exercise and 
associated skeletal muscle adaptations after fat adaptation and CHO restoration remain largely 
unknown. In this regard, the proposed role of AMPK as the ‘fuel sensor’ in skeletal muscle 
suggests that this ubiquitous protein may play a role in the altered muscle metabolism that 
accompanies fat-adaptation strategies. Figure 1.2A showed the intramyocellular and sarcolemmal 
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environment in endurance trained humans before fat adaptation strategies. Endurance training has 
been known to increase skeletal muscle FA transporter protein, FAT/CD36 (Bonen, et al., 1999; 
Koonen, et al., 2004; Simoneau, et al., 1999) and glucose transporter protein, GLUT4
(Burgomaster, et al., 2007; Daugaard, et al., 2000; Gjovaag and Dahl, 2009). Endurance training 
also increases AMPK and PDH acitivity, mitochondrial volume density and enzymes such as β-
HAD and CPT1, along with increases in both muscle glycogen (Hargreaves, 1997; Hawley, et al., 
1997) and TG concentration (Hoppeler, et al., 1973). 
A high fat diet in conjunction with endurance training during fat adaptation has been reported to
alter the muscle substrate profile where muscle TG is increased while muscle glycogen is
decreased (Figure 1.2B). This high-lipid, low-CHO environment may activate AMPK and 
increase the rates of fat oxidation observed through the AMPK-ACCβ-CPT1 signalling axis (to 
be discussed subsequently) (Figure 1.2B). In addition, AMPK may also be activated by the 
interactive effects of diet and exercise. Lessard et al. (2007) recently reported that AMPKα1 
activity was only elevated in high-fat fed rodents when they concurrently undertook an intense 
endurance training programme, further suggesting the potential of AMPK as the regulator of the 
metabolic adaptation seen in this model of nutrient-training intervention. The increases in β-HAD 
activity and FAT/CD36 observed after fat adaptation strategies could also be due to the activation 
of AMPK as it has been previously reported that AMPK activation led to an increased in β-HAD 
activity in skeletal muscle (Putman, et al., 2003), and FAT/CD36 protein content in both skeletal 
muscle (Bonen, et al., 2007) and cardiac myocytes (Chabowski, et al., 2006) (Figure 1.2B).
23
The provision of a high-CHO diet and rest during the CHO restoration phase has been 
demonstrated to restore muscle glycogen content to the level seen prior to fat adaptation 
intervention (Burke, et al., 2000; Stellingwerff, et al., 2006) (Figure 1.2C). However, it is 
currently not known if the increased muscle TG content observed after fat adaptation protocol 
would remain after this CHO restoration phase (Figure 1.2C). Should this be the case, the 
increased lipid availability may also activate AMPK to maintain the adaptations associated with 
fat adaptation protocol previously discussed, although this may happen to a lesser degree as the 
restoration of muscle glycogen may provide certain level of inhibition towards AMPK activation 
(McBride, et al., 2009) (Figure  1.2C). Taken collectively, it is likely that the adaptations seen 
previously with fat adaptation strategies are mediated in part through AMPK. 
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Figure 1.2 Endurance training and fat adaptation induced skeletal muscle adaptation 
with and without carbohydrate restoration. A) Intramyocellular and sarcolemmal 
environment in an endurance trained human before dietary manipulation, B) Fat
adaptation-induced perturbations in skeletal muscle fuel availability, adaptations and 
associated putative signalling pathways C) Fat-adaptation followed by carbohydrate 
restoration-induced perturbations in skeletal muscle fuel availability, adaptations and 
associated putative signalling pathways. Solid lines denote signalling that has been verified
experimentally after fat adaptation studies, whereas dashed lines signify putative steps that 
are yet to be validated. FAT/CD36, Fatty acid translocase; Gly, Glycogen; TG, triglyceride; 
PDH, Pyruvate dehydrogenase; ATGL, Adipose triglyceride lipase; HSL, Hormone 
sensitive lipase; αβγ, 5’ AMP-activated protein kinase; ACC, Acetyl-CoA-carboxylase; β-
HAD, β-hydroxyacyl-CoA-dehydrogenase; CPT1, carnitine palmitoyltransferase 1; P, 
Phosphorylation.
1.3.3 Training with low muscle glycogen availability
While the role of muscle glycogen in endurance performance has been well established, its role in 
skeletal muscle training adaptation is less certain. Indeed, it is not currently known whether it is a 
lack or a surplus of glycogen that triggers skeletal muscle to adapt in response to exercise training. 
In recent years, the role of glycogen has evolved from being merely a fuel store to that of a 
regulator of cellular signalling and function (Hargreaves, 2004; Hawley, et al., 2006). In this 
regard, several signalling proteins and transcription factors has been shown to possess a glycogen 
binding domain (McBride, et al., 2009; Polekhina, et al., 2003). Indeed, in recent years it has 
become evident that commencing exercise in the face of low muscle glycogen stores amplifies 
26
the activation of a number of signalling proteins, including the AMPK (Steinberg, et al., 2006; 
Wojtaszewski, et al., 2003) and the p38 MAPK (Chan, et al., 2004), two enzymes with direct 
roles in controlling the expression and activity of several transcription factors involved in 
mitochondrial biogenesis and promoting training adaptation [for review, see (Baar and McGee, 
2008; Hawley, et al., 2006)].
While the effects of acute exercise in the face of low muscle glycogen on skeletal muscle 
adaptive responses has been investigated (Chan, et al., 2004; Steinberg, et al., 2006; 
Wojtaszewski, et al., 2003), the chronic effects of training in the face of low muscle glycogen 
stores has received less attention. Only one study to date has examined the effects of a training 
programme in which a portion of exercise sessions were deliberately commenced with low 
muscle glycogen on subsequent skeletal muscle adaptation and performance (Hansen, et al., 
2005). Using an ingenious design, Hansen et al. (2005) recruited seven untrained males to 
undertake a 10-wk programme of leg knee extensor “kicking” exercise in which both of the 
subject’s legs were trained according to a different daily schedule, but the total amount of work 
undertaken by each leg over the study duration was the same: subjects trained one leg twice a 
day, every second day, whereas the contralateral (control) leg was trained daily. Interestingly, 
compared with the leg that performed daily training with normal glycogen reserves, the leg that 
commenced half of the training sessions with low muscle glycogen levels had a more pronounced 
increase in resting glycogen content and citrate synthase activity (Hansen, et al., 2005). 
Remarkably, this “train-low” approach resulted in an almost twofold greater training-induced 
increase in one-leg exercise time to fatigue compared with when participants commenced all 
training sessions in a glycogen-replete state. 
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While the results of that study (Hansen, et al., 2005) are intriguing, it was hard to discern the 
practical significance of the findings. First, the intensity of the training sessions in the Hansen et 
al. (2005) study was ‘clamped’ at a submaximal intensity for both legs. Training with high 
muscle glycogen concentration may enable an individual to train at a higher relative intensity and 
therefore achieve a more superior adaptation. Second, the mode of training (one-legged knee 
extensor kicking) and the exercise performance test utilised (submaximal kicking to exhaustion) 
provide little resemblance to normal training modes (whole-body exercise) and performance tasks 
in real world competitive races. Third, training schedules that induce chronically low muscle 
glycogen concentration may result in over-reaching or overtraining and thereby affect training 
adaptation and performance (Petibois, et al., 2003). Clearly, there appears to be a need to re-visit 
this research question in a model utilising whole-body exercise and where performance is
assessed using exercise test that mimics real life sporting situations. In addition, the subjects 
should be allowed to freely choose their maximal effort during training rather than ‘clamping’ 
their training intensity to account for differences in ability to perform training with different 
levels of muscle fuel stores. Moreover, should this training strategy be used, it should be viewed 
in the overall context of an athletes training programme, and ‘periodised’ in accordance with the 
goals of the athlete in mind. 
1.3.4 Fed versus fasted training
While performing acute exercise in the face of low muscle glycogen has been shown to increase 
the activation of AMPK and p38 MAPK (Chan, et al., 2004; Steinberg, et al., 2006; 
Wojtaszewski, et al., 2003), exercise with oral CHO ingestion has resulted in equivocal responses.
Lee-Young et al. (2006) reported no effects of CHO ingestion on AMPK signalling during 
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exercise, whereas Akerstrom et al. (2006) reported oral glucose ingestion attenuated the exercise-
induced activation of AMPK.  However, using young healthy humans as subjects, De Bock et al. 
(2005) showed that muscle TG breakdown during an acute bout of prolonged submaximal 
exercise in the fasted state was increased while this breakdown is attenuated in the CHO-fed 
state. In addition, glycogen resynthesis after exercise was also enhanced in fasted state compared 
to the CHO-fed state (De Bock, et al., 2005).
These observations have prompted two groups of researchers to investigate the effects of ‘fed’ 
versus ‘fasted’ training on skeletal muscle adaptation and performance. In one study, De Bock et 
al. (2008) recruited 20 moderately active male who undertook a 6-wk training programme (3 
day/wk, 1–2 h, 75% VO2peak). One group (n=10) performed all the training sessions in a fed state 
while the other group (n=10) performed the training sessions in fasted state. The authors (De 
Bock, et al., 2008) reported that the abundance of the fatty acid transporter protein, plasma 
membrane fatty acid binding protein (FABPpm) was increased in the group that performed
training in the fasted state (De Bock, et al., 2008). In addition, for a given initial glycogen 
content, exercise-induced glycogen breakdown was blunted in the fasted training group when 
compared to the fed training group. However, neither muscle TG breakdown nor rates of fat 
oxidation was altered by these divergent training programmes. Moreover, peak VO2, succinate 
dehydrogenase activity, GLUT4, and hexokinase II content were increased to a similar extent
between the two groups (De Bock, et al., 2008).
In a recent study, Akerstrom et al. (2009) recruited nine physically active, healthy, male subjects 
to investigate the effects of a 10-wk one-legged knee extensor training programme with or 
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without glucose ingestion on subsequent skeletal muscle adaptation and performance. The 
subjects trained one leg while ingesting a 6% glucose solution and ingested a sweetened placebo 
while training the other leg. The subjects trained their respective legs 2 hr at a time on alternate 
days, 5 days a week for 10-wk. Peak power, time to fatigue at 70% maximal power output,
glycogen content and the maximal activities of CS and β-HAD were increased to a similar extent,
while the rate of appearance and disappearance for both palmitate and glucose were not different 
when subjects trained with or without glucose supplementation (Akerstrom, et al., 2009). It was 
concluded that glucose ingestion during training does not alter training adaptation related to 
substrate metabolism, mitochondrial enzyme activity, glycogen content or performance 
(Akerstrom, et al., 2009).
In summary, it is evident that several of the nutrient-training strategies reviewed are capable of 
modulating skeletal muscle metabolism and the adaptation to a training stimulus. However, there 
is a need to further investigate the interactive effects of nutrient-training interactions on selected 
metabolic and signalling pathways such that a better understanding of these two potent stimuli 
interact to modify muscle adaptation.      
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1.4 Signalling proteins regulated by both exercise training and nutrient availability
Over the past few decades, significant progress has been made whereby certain molecular 
biology techniques such as real-time polymerase chain reaction (RT-PCR), and high-throughput 
chip assays are now available to investigate the effects of various training interventions on a 
variety of early-response genes and signalling proteins in skeletal muscle. Such advances have 
permitted not only the identification of the cellular and molecular factors that are triggered by the 
perturbations in metabolic homeostasis in response to exercise, but also the signalling 
mechanisms by which the activation of these cellular and molecular factors are translated into 
subsequent skeletal muscle adaptation. As chronic adaptation to training is believed to be the 
cumulative effects of repeated bouts of acute exercise (Hansen, et al., 2005; Hawley, et al., 2006;
Mahoney and Tarnopolsky, 2005), such acute metabolic and signalling responses to exercise may 
provide important clues of how training and nutrition interventions may modulate subsequent 
training adaptations.   
  
In this regard, acute exercise is known to result in rapid increases in cytosolic and mitochondrial 
calcium (Ca2+) and depending on the relative intensity and duration of the exercise, increases in 
AMP/ATP and PCr/[PCr + creatine (Cr)] ratio, and also muscle lactate. Again, depending on the 
relative intensity and duration, exercise is also known to result in a decrease in muscle substrate, 
such as glycogen (Coyle, et al., 1986) and triglyceride (TG) (Helge, et al., 2006; Hurley, et al., 
1986; Stellingwerff, et al., 2007b). Together, these perturbations in metabolic homeostasis, 
coupled with exercise associated mechanical stress result in the activation of several protein 
kinases that have been shown to have a role in mediating exercise-induced mitochondrial 
biogenesis, such as the AMPK and the p38 mitogen-activated protein kinase (MAPK). Of 
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particular interest is that two of the major proteins that are phosphorylated by exercise (the 
AMPK and p38 MAPK) have also been shown to be activated by the prevailing nutrient 
availability (Steinberg, et al., 2006; Watt, et al., 2006; Wojtaszewski, et al., 2003). Accordingly, 
it may be that these two signalling proteins provide a mechanistic link between nutrient 
availability and skeletal muscle adaptation in response to endurance training. 
1.4.1 5’ AMP activated protein kinase
AMPK is a heterotrimeric enzyme consisting of one α catalytic subunit and two regulatory, β and 
γ subunits. The α- and β- subunits each exist in two isoforms (α1 and α2, β1 and β2) while the γ-
subunit exists in three isoforms (γ1, γ2 and γ3). The AMPK α-subunit contains the kinase domain 
and the phosphorylation site threonine 172 which is activated by upstream kinases (Hawley, et 
al., 1996). The β-subunit contains a glycogen binding domain (McBride, et al., 2009; Polekhina, 
et al., 2003) while the γ-subunit contains two pairs of Bateman [CBS (cystathionine β-synthase)] 
domains that act as the binding site for AMP and ATP (Figure 1.3). 
The binding of AMP molecules to the Bateman domain activates AMPK while ATP competes 
with AMP for binding to these domain sites and is an inhibitor of AMPK (Scott, et al., 2004; 
Xiao, et al., 2007). During resting conditions where cells energy status is not depressed, ATP is 
believed to be predominantly bound to the Bateman domains and AMPK molecules are inactive 
(Xiao, et al., 2007) (Figure 1.4). However, during muscular contraction (i.e. exercise), ATP is 
hydrolysed into adenosine diphosphate (ADP) before being converted rapidly into AMP by the 
adenylate kinase reaction. Depending on the intensity and duration of the contraction (i.e. 
exercise), this in turn leads to an accumulation of AMP and consequently AMPK is activated 
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(Figure 1.4). AMPK can also be phosphorylated by upstream kinases such as LKB1 and 
calcium/calmodulin-dependant kinase kinase (CaMKK) in response to changes in cellular 
concentrations of AMP and calcium (Ca2+).
α-subunit
β-subunit
  
γ-subunit
Figure 1.3 Typical domain structure of the α, β and γ subunits of AMPK [reproduced 
from Hardie, et al. (2006)].
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Figure 1.4 Structure of AMPK and its regulation by AMP, ATP, rest and exercise.
In line with it’s proposed role as the ‘metabolic master switch’, AMPK is activated by conditions 
resulting in cellular metabolic stress by either an increase in the rate of ATP hydrolysis, such as 
during exercise, or during events where ATP production is inhibited, such as during ischaemia 
and hypoxia. This activation of AMPK subsequently results in the activation of cellular processes 
that increase energy production [e.g., increased glucose uptake and/or fat oxidation (Merrill, et 
al., 1997)] while concomitantly inhibiting processes that require energy consumption (e.g., 
protein synthesis) to restore energy levels. In this regard, AMPK is believed to regulate fatty acid 
oxidation by phosphorylating and inactivating it’s downstream target acetyl-CoA-carboxylase-β 
(ACCβ). The decrease in the activity of ACCβ in turn leads to the lowering of malonyl CoA 
levels and subsequently relieving malonyl CoA inhibition on carnitine palmitoyltransferase 1 
(CPT1). Since CPT1 is the rate limiting enzyme that controls the long-chain FA entry into the 
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mitochondrial matrix, the activation of AMPK and subsequent activation and inhibition of ACCβ 
resulted in an increase in FA oxidation (Winder and Hardie, 1996).
The role of AMPK in mediating exercise-induced mitochondrial biogenesis has been 
demonstrated in animal studies where pharmacological agents have been used to activate AMPK. 
In their seminal studies, Winder and colleagues (Holmes, et al., 1999; Winder, et al., 2000)
showed that chronic activation of AMPK by aminoimidazole carboxamide ribonucleotide 
(AICAR) injections increased the protein expression of hexokinase, GLUT4, and several 
mitochondrial enzymes in rat skeletal muscle, an effect similar to that of endurance training. In a 
later study, Zong et al. (2002) fed mice with β-guanidinopropionic acid (GPA), a creatine 
analogue that leads to increases in intramuscular AMP/ATP ratio. The authors (Zong, et al., 
2002) reported that AMPK activity and subsequent mitochondrial biogenesis was only observed 
in the control mice but not in the experimental mice overexpressing a dominant-negative AMPK 
in muscle. Together, these results indicated that AMPK activation increases mitochondrial 
biogenesis and may mediate some of the mitochondrial adaptations that take place in response to 
exercise training.    
In human skeletal muscle, AMPK can be activated during exercise in a rapid, intensity-dependant 
and isoform specific manner. Chen et al. (2000) demonstrated that both AMPKα1 and -α2 
isoforms are rapidly activated during a 30-s maximal sprint cycle exercise. With respect to 
exercise intensity, Fujii et al. (2000) reported that AMPK activity was significantly increased in 
the vastus lateralis muscle following 20 min of cycling at 70% but not at 50% VO2peak while 
AMPK has also been demonstrated to be activated by four 30-s "all out" sprint cycle bouts 
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(Gibala, et al., 2009). AMPK isoform specific activation has also been reported by Chen et al. 
(2003). Specifically, the activation status of both AMPKα1 and –α2 activity was increased when 
exercise intensity was increased from ~40% VO2peak to ~60% VO2peak but when the exercise 
intensity was further increased to ~80% VO2peak, only AMPKα2 but not α1 activity was 
increased. With regards to exercise duration, AMPK activity was found to be increased during 
the first 5 min of moderate (60% of VO2peak) cycling with further rises observed after 30 min of 
exercise (Stephens, et al., 2002). AMPK has also been shown to become progressively more 
phosphorylated during prolonged (~210 min) low intensity (45% VO2peak) cycling exercise 
(Wojtaszewski, et al., 2002). 
The activation of AMPK by exercise is reduced by endurance training (McConell, et al., 2005; 
Nielsen, et al., 2003; Yu, et al., 2003). Yu et al. (2003) demonstrated that the AMPK activation in 
response to a single bout of exercise (undertaken at the same relative intensity) was reduced in 
well-trained endurance athletes compared to untrained sedentary subjects matched for age and 
body mass. In agreement with Yu et al. (2003), Nielsen et al. (2003) reported that 
phosphorylation states of AMPKα at theonine 172 was significantly blunted in seven well-trained 
endurance athletes compared to seven young, healthy sedentary men. In another study, McConell 
et al. (2005) showed that AMPK activation in response to exercise was attenuated when untrained 
subjects went through a short-term (10 days) endurance training programme. Indeed, it appears 
that intense (85% VO2peak) exercise is required to activate AMPK in well-trained individuals 
(Clark, et al., 2004).
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AMPK expression has also been shown to be regulated by endurance training in both cross 
sectional and longitudinal training studies. Comparing seven well-trained endurance athletes to 
seven young, healthy sedentary men, Nielsen et al. (2003) reported that the protein content of 
AMPKα1 isoform was significantly higher in the well-trained endurance athletes. Frosig et al. 
(2004) recruited eight healthy young men to undertake supervised one-legged knee extensor 
endurance training for 3 weeks. In response to the training programme, the protein content of 
AMPK-α1, -β2 and -γ1 isoform was increased in the trained leg by 41, 34 and 26% respectively,
whereas the regulatory γ3 isoform was decreased by 62%. However, no effect was observed on 
the remaining α2, β1 and γ2 isoform. More importantly was the observation that the activity of 
the catalytic subunit α1 and α2 at rest was elevated by 94 and 49% respectively, indicating that 
AMPK activity is upregulated by endurance training.
While the AMPK activity has been shown to be upregulated by training, it is interesting to note 
that the AMPK activation can also be regulated by substrate availability in human skeletal muscle. 
Wojtaszewski et al. (2003) reported that compared to a glycogen loaded state (900 mmol/kg dry 
wt), the resting activities of the AMPK-α1 and -α2 isoform were significantly higher by 160 and 
145% respectively when muscle glycogen content was reduced (~160 mmol/kg dry wt.) while the 
activity of the AMPKα2 isoform was also found to be higher when exercise (1 hour cycle at 70% 
VO2peak) was performed in the face of low glycogen availability (Wojtaszewski, et al., 2003). In 
agreement with Wojtaszewski et al. (2003), Steinberg et al. (2006) also reported that when seven 
males performed 60-min of exercise on two occasions, commencing exercise with low compared 
to normal glycogen levels was associated with elevated AMPKα2 activity and increased 
AMPKα2 translocation to the nucleus . In support of this contention, AMPK has been shown to 
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possess a glycogen binding domain within its β isoform (McBride, et al., 2009; Polekhina, et al., 
2003) and recently, McBride et al. (2009) provided the first evidence that AMPK activity is 
indeed inhibited by glycogen. 
However, it is important to note that the glycogen depleted state in Wojtaszewski et al. (2003)
also resulted in a two fold increase in plasma long chain FA’s and the dietary intervention used to 
create the glycogen depleted state in both the studies of (Steinberg, et al., 2006) and
(Wojtaszewski, et al., 2003) may also have resulted in increased muscle TG stores. Watt et al. 
(2006) reported that the incubation of L6 skeletal muscle myotubes with palmitate and linoleate 
increased AMPK activity significantly and that this increased in AMPK activity occurred in the 
absence of detectable changes in AMP and glycogen content, indicating that fatty acids may have 
a modulatory role on AMPK activity (Watt, et al., 2006). While most studies have proposed a 
role for muscle glycogen availability in modifying metabolic signals (i.e. AMPK), the role of the 
diet-induced increase in fat availability should not be overlooked.
1.4.2 p38 mitogen-activated protein kinase 
p38 MAPK is a member of the mitogen-activated protein kinase family that consists of p38 
MAPK, extracellular signal-regulated kinases (ERK) 1 and 2 (ERK1/2), c-Jun NH2-terminal
kinases (JNK) and ERK5 (Kramer and Goodyear, 2007). p38 MAPK is activated by various 
stimuli such as muscular contraction, insulin, environmental stress and proinflammatory 
cytokines (Raingeaud, et al., 1995; Somwar, et al., 2000; Tsakiridis, et al., 1996). p38 MAPK has 
been implicated to be involved in a variety of diverse roles including skeletal muscle myogenic 
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cell differentiation (Zetser, et al., 1999), regulation of muscle atrophy and mitochondrial 
biogenesis.  
The activation of p38 MAPK during exercise has been observed during treadmill exercise in 
rodents (Goodyear, et al., 1996; Nader and Esser, 2001), cycling ergometry (Benziane, et al., 
2008; Widegren, et al., 1998), marathon running (Boppart, et al., 2000; Yu, et al., 2001) and 
sprint cycling (Gibala, et al., 2009) in humans. The role of p38 MAPK in mediating 
mitochondrial biogenesis in response to exercise has been demonstrated in a series of 
experiments utilising animals, cell and transgenic models (Akimoto, et al., 2005). These authors
(Akimoto, et al., 2005) initially showed that voluntary running exercise concurrently increased 
p38 MAPK and peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α), a
transcriptional co-activator that promotes mitochondrial biogenesis (to be discussed subsequently) 
in mouse skeletal muscle (Akimoto, et al., 2005). Using C2C12 cultured myocytes, they then 
went on to show that the activation of p38 MAPK stimulated PGC-1α promoter activity and that 
this increased in PGC-1α promoter activity can be blocked by specific p38 inhibitors, or 
dominant negative p38 (Akimoto, et al., 2005). On a more functional note, they showed that 
constitutively over-expressed skeletal muscle-specific p38 in transgenic mice resulted in 
enhanced PGC-1α and cytochrome oxidase IV protein expression in fast-twitch skeletal muscles
(Akimoto, et al., 2005). Taken collectively, these results suggested that p38 MAPK plays a role 
in mediating mitochondrial biogenesis in response to exercise.
Interestingly, the p38 MAPK has also been shown to be regulated by substrate availability in 
human skeletal muscle (Chan, et al., 2004). Chan et al. (2004) had eight subjects performed 60 
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min of exercise on two occasions; either with prior ingestion of a normal (Con) or low 
carbohydrate (LCHO) diet that reduced pre-exercise muscle glycogen content. Chan et al. (2004)
found that the phosphorylation of nuclear p38 was greater both at rest and after exercise in the 
group that performed the exercise with low muscle glycogen content. Again, similar to studies 
that reported regulation of AMPK by muscle glycogen availability (Steinberg, et al., 2006; 
Wojtaszewski, et al., 2003), Chan et al. (2004) may have overlooked that their dietary 
intervention may also have altered muscle lipid profile and that these changes in lipid profile may 
have a role on the increased p38 MAPK activation. Nevertheless, the important message is the 
p38 MAPK appears to be regulated by muscle substrate availability and in view of the role of the 
p38 MAPK in mediating mitochondrial biogenesis in response to exercise, p38 MAPK may serve 
as one of the candidate signalling proteins that can potentially mediate the interactive effects of 
nutrient availability and exercise training.
1.4.3 Downstream signalling pathways of AMPK and p38 MAPK
Peroxisome proliferator-activated receptor gamma coactivator-1α 
The AMPK and p38 MAPK are believed to mediate mitochondrial biogenesis in response to 
exercise through a similar downstream target, PGC-1α. PGC-1α is a member of the family of 
transcriptional regulators consisting of PGC-1α, peroxisome proliferator-activated receptor 
gamma (PPARγ) coactivator 1-β (PGC-1β) and PGC-1 related co-activator (PRC). Being a 
transcriptional co-activator, PGC-1α does not bind to DNA itself in a sequence-specific manner 
(Liang and Ward, 2006; Puigserver and Spiegelman, 2003). Instead, it recruits histone acetyl 
transferase (HAT) enzymes to a number of transcription factors such as the myocyte enhancer 
factor 2 (MEF2), estrogen related receptor α (ERRα), nuclear respiratory factor-1 (NRF-1) and -2 
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(NRF-2) and subsequently modifies the chromosome structure to one that favours transcriptional 
activation to regulate glucose and FA metabolism, mitochondrial biogenesis, and muscle fiber 
type transformation (Czubryt, et al., 2003; Handschin, et al., 2003; Lin, et al., 2002; Puigserver, 
et al., 1998; Vega, et al., 2000; Wu, et al., 1999).
PGC-1α signalling can be increased by either increasing its activity or protein expression. Wright 
et al. (2007) provided first evidence that the increases in mitochondrial enzyme expression 
occurred before the increased in PGC-1α protein expression and concluded that exercise rapidly 
increases PGC-1α activity to mediate the initial phase of the exercise-induced adaptive increase 
in muscle mitochondria content (Wright, et al., 2007). On the other hand, the increased in PGC-
1α protein has been shown to be the result of increased transcription of PGC-1α gene (Akimoto, 
et al., 2004). This increased in the transcription of PGC-1α gene is regulated by proteins binding 
to either the MEF2 or cyclic AMP response elements (CRE) within the PGC-1α promoter
(Akimoto, et al., 2008; Akimoto, et al., 2004). 
Both PGC1-α mRNA and protein expression have been reported to increase in response to
exercise. In both mice and humans, PGC-1α mRNA was reported to be increased by ~1.5–10 fold 
after a single bout of exercise (Baar, et al., 2002; Gibala, et al., 2009; Mathai, et al., 2008; 
Pilegaard, et al., 2003; Terada, et al., 2002; Terada, et al., 2005; Wright, et al., 2007). However, 
the increased in PGC-1α protein expression after exercise has not been consistently demonstrated
in human skeletal muscle. Mathai et al (2008) reported that skeletal muscle PGC-1α protein was
increased in response to an acute bout of exercise whereas it was unchanged after exercise in 
another study (Gibala, et al., 2009). Nevertheless, the activation of PGC-1α has also been shown 
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in cell culture models by stimulus that mimic aspects of endurance exercise (Akimoto, et al., 
2005; Irrcher, et al., 2003; Lee, et al., 2006; Ojuka, et al., 2003). Terada et al. (2005) further 
showed that PGC-1α activation during exercise is intensity dependant with greater activation 
observed after high intensity intermittent compared to low intensity prolonged swimming 
exercise (Terada, et al., 2005). Collectively, these results demonstrate that PGC-1α is activated by 
exercise.
PGC-1α has been postulated to be a key regulator of mitochondrial biogenesis. Over-expressing 
PGC-1α in mice results in greater expression of skeletal muscle mitochondrial enzymes and 
oxidative capacity while electrically stimulating muscles from these transgenic mice is associated 
with a 3-fold increase in time to fatigue compared to their wild-type littermate (Lin, et al., 2002).
However, as over-expression of PGC-1α often resulted in a 10-30 fold increased in PGC-1α 
expression, it has been questioned whether such large perturbations can be achieved with 
physiological stimuli (i.e. exercise training). To address this question, Benton et al. (2008) used 
an electrotransfection procedure to over-express PGC-1α rapidly (2 weeks), within physiologic 
limits, in rat tibialis anterior muscle in one limb while the contralateral muscle served as control.
They (Benton, et al., 2008) reported a modest (24%) increase in PGC1-α protein expression such 
that might be expected in response to exercise (Mathai, et al., 2008), or after endurance training 
(Burgomaster, et al., 2008) in human skeletal muscle. This modest increased in PGC1-α was 
sufficient to induce mitochondrial biogenesis as shown in an increased in citrate synthase 
activity, cytochrome c oxidase subunit 4 (COX IV) and mitochondrial DNA while concomitantly 
increased FA oxidation in subsarcolemmal mitochondria (Benton, et al., 2008). Together, these 
results suggested that PGC1-α is indeed a powerful regulator of mitochondrial biogenesis.
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The AMPK and p38 MAPK signalling pathways are believed to converge at PGC-1α to mediate 
mitochondrial biogenesis (Figure 1.6). There are several mechanisms proposed by which AMPK 
interacts with PGC-1α to induce mitochondrial adaptations. Recently, using primary muscle cells, 
Jager et al. (2007) showed that the effects of AMPK on gene expression of glucose transporter 4 
(GLUT4), mitochondrial genes, and PGC-1α itself are almost entirely dependent on the function 
of PGC-1α protein. In addition, these workers (Jager, et al., 2007) demonstrated that AMPK 
phosphorylated PGC-1α directly both in vitro and in cells and these direct phosphorylations of 
the PGC-1α protein at threonine-177 and serine-538 were required for the PGC-1α-dependent 
induction of the PGC-1α promoter (Jager, et al., 2007). 
AMPK may also regulate PGC-1α expression by phosphorylating the transcriptional repressor 
histone deacetylase 5 (HDAC5). During its inactive form, HDAC5 interacts with MEF2 and 
modifies the chromosome structure to one that silences transcription (Baar and McGee, 2008; 
McGee, 2007; McGee and Hargreaves, 2008; McKinsey, et al., 2000; McKinsey, et al., 2001).
Phosphorylation of HADC5 at site Ser259 and Ser498 disrupts the interaction between MEF2 
and HDAC5 and leads to the nuclear export of HDAC5 by the 14-3-3 chaperone protein. This 
results in subsequent chromatin remodeling and MEF2 transcriptional activity is enhanced to 
increase PGC-1α expression (Baar and McGee, 2008; Czubryt, et al., 2003; McGee, 2007; 
McGee and Hargreaves, 2008; McKinsey, et al., 2000; McKinsey, et al., 2001) (Figure 1.5).
AMPK has been shown to be able to phosphorylate HDAC5 at Ser259 and Ser498 (McGee, et al., 
2008a) and prolonged submaximal exercise has also been shown to increase AMPKα2 content in 
the nucleus of human muscle cell (McGee, et al., 2003). As such the AMPK-HDAC5-MEF2 axis
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has been proposed as one of the pathways by which AMPK regulate PGC-1 α and subsequent 
mitochondrial biogenesis.
As noted above, the CRE binding proteins are needed for the transcription of PGC-1α. A recent 
study by Thomson et al. (2008) demonstrated that the CRE binding protein (CREB) is a direct 
downstream targets of AMPK. This result indicates that AMPK may also increase PGC-1α
transcription by phosphorylating CREB to induce mitochondrial biogenesis in response to 
exercise (Figure 1.6).
On the other hand, p38 MAPK is believed to modulate PGC-1α activity by two putative 
mechanisms. PGC-1α activity can be regulated by p160myb, a repressor protein that can 
powerfully inhibit PGC-1α function by blocking it’s interactions with transcription factors (Fan, 
et al., 2004). The phosphorylation of PGC-1α by p38 MAPK has been shown to disrupt this 
association between p160myb and PGC-1α (Fan, et al., 2004). Consequently, PGC-1α can be 
recruited to transcription factors to increase it’s transcriptional activity (Fan, et al., 2004)
(Figure 1.6). In a recent study, Akimoto et al. (2005) demonstrated that the p38 MAPK mediate 
increased in PGC-1α promoter activity was enhanced by increased expression of the 
downstream transcription factor activating transcription factor 2 (ATF2), and completely 
blocked by a dominant negative ATF2. These results indicated that ATF2 is required for the 
increased in the transcription of PGC-1α through p38 MAPK activation and further provide 
another mechanistic explanation by which exercise and thus p38 MAPK activation may 
mediate mitochondrial biogenesis (Akimoto, et al., 2005) (Figure 1.6).  
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In summary, the introduction of molecular biology techniques into exercise metabolism study 
has made possible the identification of cellular and molecular factors that may provide the link 
between endurance training and mitochondrial biogenesis and how these factors are regulated 
by nutrient availability and/or the interactive effects of nutrient availability and endurance 
training.  
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Figure 1.5 Schematic diagram showing the proposed mechanism by which AMPK 
increase PGC-1α transcription through phosphorylation of histone deacetylase 5 (HDAC5). 
αβγ, 5’ AMP activated protein kinase; MEF2, myocyte enhancer factor 2; PGC-1α,  
Peroxisome proliferator-activated receptor- coactivator-1α; 14-3-3, 14-3-3 chaperone 
protein [adapted from Baar and McGee (2008)].
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Figure 1.6 Putative downstream signalling pathways of AMPK and p38 MAPK in 
mediating skeletal muscle mitochondrial biogenesis. Bars denote inhibition and arrows 
denote activation. CHO, carbohydrate; αβγ, AMP-activated protein kinase; HDAC5, 
histone deacetylase 5; CREB, cyclic AMP response element binding protein; ATF2, 
activating transcription factor 2; p160myb, p160 myb binding protein; PGC-1α, Peroxisome 
proliferator-activated receptor gamma coactivator-1α. 
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Chapter Two
Aims of Thesis
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Aims of thesis
The overall aim of the experiments undertaken for this thesis was to investigate how altering 
skeletal muscle fuel stores interacts with endurance exercise to modify skeletal muscle 
adaptation. A specific aim was to study some of the potential cell signalling events that underlie 
the observed perturbations in muscle metabolism. In this regard, endogenous CHO and lipid 
stores in muscle were altered by manipulating dietary intake and/or the training stimulus. The 
scope of the investigations undertaken for this thesis was limited to endurance exercise training 
adaptation in well-trained humans. 
The literature review (Chapter One) provides an overview of the role of nutrient availability
and exercise training on skeletal muscle adaptation. Subsequently, several nutritional strategies 
that have been used to modify fuel stores in muscle with a view to enhancing exercise capacity 
and/or training adaptation are discussed. In addition, potential mechanisms that may influence 
skeletal muscle responses to the various nutrient-training interventions are also discussed. 
In the first experiment described in Chapter Three, a short term model of ‘dietary periodisation’ 
known as fat adaptation with carbohydrate restoration was utilised to study skeletal muscle 
adaptation. Well-trained cyclists undertook their normal high volume training while consuming 
either a high carbohydrate or high fat diet for 5 days followed by 1 day of ‘carbohydrate 
restoration’ and rest. The main objective of this experiment was to investigate potential 
mechanisms that underlie the previously observed increases in rates of whole-body fat oxidation 
that persist after ‘fat adaptation and CHO restoration’. The hypothesis to be tested in this study 
was that a short-term period of ‘fat adaptation’ followed by carbohydrate restoration would 
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increase resting muscle triglyceride concentrations and that changes in lipid availability per se 
would modify AMPK signalling to increase the rates of fat oxidation at rest and during 
submaximal exercise.
In the second study described in Chapter Four, well-trained endurance cyclists/triathletes 
undertook a chronic (3-wk) training programme in which subjects either trained once everyday 
for 6 consecutive days or twice every second day. The main objective of this study was to 
investigate the effects of these two different training regimens on 1) skeletal muscle fuel storage 
profile, 2) training capacity and endurance performance, 3) whole-body substrate metabolism 
during submaximal exercise and 4) several mitochondrial enzymes and signalling proteins with 
putative roles in promoting training adaptation. The hypothesis to be tested in this study was that 
well-trained athletes would have maximised their training adaptation and that further gains in 
skeletal muscle adaptation and performance would be minimal, irrespective of whether they 
trained with low or normal levels of muscle glycogen.
In the final experiment described in Chapter Five, well-trained endurance cyclists/triathletes 
participated in an acute exercise study in which they undertook either a single session of training 
once daily or trained twice the same day. The primary aim of this experiment was to elucidate the 
potential mechanisms that may help explain the superior training adaptation observed in the 
previous study (Chapter Four) in which training twice every second day promoted selected 
muscle adaptations to a greater extent than training daily. The hypothesis to be tested in this study
was that performing intense endurance exercise in the face of low muscle glycogen concentration 
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would result in increased activation of AMPK and p38 MAPK and some of their downstream 
substrates.
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Chapter Three
Fat adaptation followed by carbohydrate restoration increases 
AMPK activity in skeletal muscle from trained humans
Adapted from: Yeo W.K., Lessard S.J., Chen Z.P., Garnham A.P., Burke L.M., Rivas D.A., 
Kemp B.E., Hawley J.A. Journal of Applied Physiology Nov;105(5):1519-26.
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3.1 Introduction 
Short-term (<1 wk) manipulation of dietary macronutrient intake is associated with marked 
changes in skeletal muscle gene expression (Arkinstall, et al., 2004; Cameron-Smith, et al., 2003; 
Jump and Clarke, 1999), substrate stores (Zderic, et al., 2004), metabolic flux and fuel oxidation 
(Coyle, et al., 2001; Horowitz, et al., 1997; 1999). Exercise training also results in striking 
modifications in muscle gene expression (Freyssenet, 2007), energy reserves, and the relative 
contribution of fuels to the energetic demands of muscle (Coggan, et al., 1990). Accordingly, the 
extent to which acutely altering substrate availability might modify the training impulse has been 
a key research area among exercise physiologists and sport nutritionists for several decades [for 
review see Hawley et al. (2006)]. Indeed, evidence is accumulating that nutrient manipulation can 
serve as a potent modulator of many of the acute responses to both endurance (Hansen, et al., 
2005) and resistance exercise (Churchley, et al., 2007; Creer, et al., 2005).
During recent years, a series of independent but related studies have been performed by several 
investigators to examine the effects of a practical “dietary periodisation” strategy in well-trained 
endurance athletes on selected aspects of metabolism and exercise performance (Burke, et al., 
2000; Burke, et al., 2002; Carey, et al., 2001; Stellingwerff, et al., 2006; Stepto, et al., 2002). The 
results of these studies have shown that short-term (5 d) exposure to a high-fat diet while 
undertaking high-volume, intense training followed by 1 d of rest and “carbohydrate restoration” 
results in greater rates of whole-body fat oxidation and decreased rates of muscle glycogenolysis 
during submaximal [70% peak O2 uptake (VO2peak)] cycling than when subjects undertake the 
same training and consume an isoenergetic high carbohydrate diet (Burke, et al., 2000; 
Stellingwerff, et al., 2006). The decreased rate of muscle glycogenolysis during exercise 
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following fat adaptation with carbohydrate restoration can, in part, be explained by decreased 
pyruvate oxidation via PDH flux (Stellingwerff, et al., 2006). However, it is not clear what 
precise metabolic signal(s) accounted for the marked shifts in substrate utilisation during exercise. 
In this regard, it was suggested that AMP-activated protein kinase (AMPK) may provide a direct 
link between intracellular signalling events and subsequent substrate selection in exercising 
muscle (Hardie and Sakamoto, 2006; Winder, 2001). In support of this hypothesis, diet-exercise 
manipulation that result in low muscle glycogen content are associated with increased resting 
AMPK activity (Steinberg, et al., 2006; Wojtaszewski, et al., 2003) and elevated phosphorylation 
of AMPK’s downstream target, β-acetyl-CoA carboxylase (ACCβ) Ser221 compared to high 
glycogen stores (Wojtaszewski, et al., 2003). Furthermore, the degree of AMPK activation during 
submaximal exercise was also shown to be dependent on the fuel status of the contracting 
musculature, with AMPK activity elevated to a greater extent in muscle with low compared to 
high glycogen levels (Wojtaszewski, et al., 2003).  
While the findings of Wojtaszewski et al. (2003) imply that glycogen availability per se may 
modulate AMPK activity, it cannot be ruled out that the diet-exercise regimens used to 
differentiate glycogen concentration in those studies also resulted in significant changes in 
muscle lipid availability [i.e. increased muscle triacylglycerol (TG)]. Accordingly, the observed 
changes in AMPK activation may have been more a consequence of lipid-induced rather than 
carbohydrate-induced effects on this enzyme. In this regard, Lessard et al. (2007) recently 
showed that endurance training in high-fat fed rats was associated with increased AMPKα1 
activity, whereas AMPKα2 activity was elevated by high-fat feeding alone and was not increased 
further by exercise training (Lessard, et al., 2007). Accordingly, the aim of the current study was 
54
to investigate the effect of a diet-exercise protocol known to be associated with elevated rates of 
fat oxidation independent of muscle glycogen availability on AMPK signalling at rest and during 
subsequent submaximal exercise. It was hypothesised that fat adaptation followed by 
carbohydrate restoration would increase resting muscle triglyceride concentrations and that 
changes in lipid availability per se would modify AMPK signalling at rest and during exercise. 
3.2 Methods
3.2.1 Subjects and preliminary testing
Eight endurance-trained male cyclists or tri-athletes [body mass (BM) 70.2 ± 1.8 kg; age 31.6 ± 
2.3 yr; peak O2 uptake (VO2peak) 61.5 ± 1.5 mL/kg/min, peak sustained power output (PPO) 339.9 
± 5.8 W; values are mean ± SE] were recruited to participate in this study which was approved by 
the Human Research Ethics Committee of RMIT University. Subjects were fully informed about 
the possible risks of all procedures before providing their written consent. One week prior to 
experimental testing, each subject undertook an incremental cycling test to exhaustion on an 
electronically braked cycle ergometer (Lode, Groningen, The Netherlands). The initial testing 
protocol has been described in detail previously (Hawley and Noakes, 1992). In brief, the 
subjects started the test at an intensity equivalent to 3.33 W/kg BM. This initial intensity was
maintained for 150 s and thereafter was increased by 50 W for a further 150 s. After the second
stage the exercise intensity was increased by 25 W every 150 s until the subjects reached fatigue, 
which always coincided with either a drop in rate of greater than 10 rpm, a respiratory exchange
ratio (RER) greater than 1.10, or both (Hawley and Noakes, 1992). During the maximal test and 
the subsequently described experimental trials, subjects breathed through a Hans Rudolph two 
way non-rebreathing valve and mouthpiece attached to a gas analysis system (Parvomedics, Utah, 
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U.S.A) interfaced to a computer, which calculated the instantaneous rates of O2 consumption 
(VO2), CO2 production (VCO2), minute ventilation (VESTPD), and the RER every 15 s from 
conventional equation (Péronnet and Massicotte, 1991). Before each maximal test and all 
experimental trials, the analyzers were calibrated with commercially available gases of known O2
and CO2 content. VO2peak was defined as the highest O2 uptake a subject attained during any 60 s 
of the test while PPO was calculated from the last completed work rate plus the fraction of time 
spent in the final noncompleted work rate multiplied by 25 W. This value was used to determine 
the power output corresponding to 70% of each subject’s VO2peak (63% of PPO) to be used in the 
subsequently described experimental trials. The maximal test session and all experimental trials 
were performed under standard laboratory condition (18-22ºC, 40-50% relative humidity) and 
subjects were fan cooled during all these sessions.    
3.2.2 Overview of study design
The experimental protocol is shown in Figure 3.1 and has been described in detail previously 
(Burke, et al., 2000). In brief, each subject undertook two 7-day trials in a randomised, crossover 
design separated by a 2-wk washout period. The interventions consisted of prescribed supervised 
training while undertaking either a 5-day high-fat diet followed by a 1-day of high CHO 
restoration (FAT-adapt) or a 6-day high-CHO diet (HCHO). During FAT-adapt, the subjects 
were prescribed a high-fat (4.6 g/kg/d fat, 68% of energy), low CHO (2.5 g/kg/d CHO, 17% of 
energy) diet supplying 0.25 MJ/kg BM. HCHO was an isoenergetic diet providing 10.3 g/kg/d 
and 70% of energy from CHO and 1.0 g/kg/d and 18% of energy from fat. Protein content was 
maintained at 2.3 g/kg/d during both trials and diets were constructed to maximize, or at least 
match, absorbable energy. Fiber intake was kept to a daily mean intake of <50 g and matched to 
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within 5 to 10 g each day between dietary treatments. All meals and snacks were supplied to 
subjects, with diets being individualized for food preferences as well as BM. Subjects received 
their food in pre-prepared packages and were required to keep a food checklist to note their 
compliance to the dietary instructions and their intake of any additional food or drinks. Every two 
days they met with a dietician to receive new food parcels and check their adherence to the 
previous days' diet. The high-CHO diet prescribed in this study is similar in composition to that 
recommended by sports nutritionists for endurance trained athletes (Burke, 2003). However, the 
high-fat diet is far removed from the nutritional energy sources typically consumed by our 
subjects. While an ad libitum diet group may provide insight into diet-training interactions, the 
addition of such a group was not considered within the current experimental design.
On the morning of day 1 and day 5 of each trial, subjects reported to the laboratory after a 12- to 
14-h overnight fast and undertook a 20-min steady state ride at 70% of VO2peak. Pulmonary gas 
exchange data were collected for the last 5-6 min to calculate the rates of whole body fat and 
CHO oxidation. This ride was immediately followed by a high intensity interval training session 
consisting of 8 repetitions of 5 min work bouts at 85% of VO2peak with 1 min of recovery at 100 
W. The metabolic demands associated with this interval training session have been described in 
detail previously (Stepto, et al., 2001). The intent of this ride was to lower the muscle glycogen 
concentrations on the first day and initiate a rapid differentiation between dietary treatments on 
the basis of their ability to restore depleted muscle glycogen stores. On day 6 of both the FAT-
adapt and HCHO trials, subjects were required to rest and ingest a high carbohydrate diet (10.3 
g/kg BM). 
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Figure 3.1. Overview of the study design and experimental trial. CHO, carbohydrate; VO2peak, peak oxygen uptake.
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3.2.3 Experimental trial 
On the morning of day 7, subjects returned to the laboratory after a 12- to 14-h overnight fast to 
undertake a 1 h steady state ride at 70% of VO2peak. On arrival in the laboratory, a single leg was 
prepared for muscle biopsies, and two incisions were made 2–3 cm apart along the vastus 
lateralis muscle. A resting muscle sample was then taken using the percutanous biopsy technique 
with suction applied. After resting for 10 min, subjects began the 60-min steady state ride and a 
second biopsy was obtained within 10 seconds on completion of the ride while subjects remained 
seated on the ergometer (Figure 3.1). All muscle biopsies were rapidly frozen in liquid N2 within 
seconds of the designated time point for collection and stored at -80ºC until subsequent analysis. 
3.2.4 Analytical Procedures
Rates of fat and CHO oxidation
Whole body rates of carbohydrate and fat oxidation (g/min) were calculated from the respiratory 
data collected during the last 5-6 min of the 20-min steady state ride on day 1 and day 5 and 
during the last 5 minutes of every 20 minutes of the steady state ride at 70% VO2peak. The 
calculations were made from VCO2 and VO2 measurements, assuming a nonprotein RER value, 
according to the following equations (Péronnet and Massicotte, 1991).
CHO oxidation = 4.585 VCO2 - 3.226 VO2
Fat oxidation = 1.695 VO2 - 1.701 VCO2
Total fat and carbohydrate oxidation during the 60 min steady state ride were estimated by 
calculating the area under the oxidation (g/min) versus time curves for each subject. Rates of 
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CHO oxidation (mol/kg/min) were determined by converting the rate of CHO oxidation (g/min) 
to its molar equivalent assuming 6 mol of O2 are consumed and 6 mol of CO2 produced for each 
mole (180 g) oxidised. Rates of fatty acid oxidation (mol/kg/min) were determined by 
converting the rate of triglycerol oxidation (g/min) to its molar equivalent assuming the average 
molecular weight of human triglyceride to be 855.3 g/mol and multiplying the molar rate of 
triglyceride oxidation by 3, because each molecule contains three molecules of fatty acids. 
Muscle glycogen and triacylglycerol concentration
Approximately 40-50 mg of muscle was freeze-dried and powdered with all visible blood and 
connective tissue removed. The freeze-dried muscle sample was then divided into two aliquots. 
The first aliquot (~3 mg) was extracted with 250 µL of 2 M hydrochloric acid, incubated at 
100ºC for 2 hr and then neutralized with 750 µL of 0.67 M sodium hydroxide. Glycogen 
concentration was determined via enzymatic analyses with fluorometric detection (Jasco FP-750 
spectrofluorometer, Easton, MD) and was expressed as micromoles of glycogen per gram of dry 
weight mol/g dry wt. (Churchley, et al., 2007).
The second aliquot (~7 mg) was used for the determination of muscle triacylglycerol content, as 
previously described (Frayn and Maycock, 1980). In brief, lipid was extracted by Folch extraction 
(Folch, et al., 1957), the triacylglycerol was then saponified in an ethanol/potassium hydroxide 
solution at 60ºC, and glycerol content was determined fluorometrically and expressed as mol/g 
dry wt. 
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AMPK Signalling
Approximately 60 mg of wet muscle were homogenised in buffer A (50 mM Tris HCl, pH 7.5, 1 
mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 50 mM NaF, 5 mM Na pyrophosphate, 10% 
glycerol, 1% Triton X-100, 10 µg/ml trypsin inhibitor, 2 µg/ml aprotinin, 1 mM benzamidine, 
and 1 mM phenylmethylsulfonyl fluoride) and the homogenate was then centrifuged at 20,000 g 
for 25 min.  The supernatant was aliquoted and the total protein concentration was determined by 
bicinchoninic acid method (Pierce Chemical, Rockford, IL). The aliquots were then stored at -
80ºC until further analysis. 
Immunoprecipitation
Approximately 2.5 mg of protein from the supernatants were incubated with AMPK1 or 
AMPK2 antibody bound protein A-Sepharose beads (6 MB; Amersham Biosciences, Uppsala, 
Sweden) for 2 h at 4°C. The polyclonal antipeptide antibodies to AMPK1 and AMPK2 were 
raised to non-conserved regions of the AMPK1 (rat 231–251) and AMPK2 isoforms (rat 351–
366). The immunocomplexes were washed with PBS and suspended in 50 mM Tris.HCl (pH 7.5) 
buffer for the AMPK activity assay. The AMPK activities in the immune complexes were 
measured in the presence of 200M AMP. Activities were calculated as picomoles of phosphate 
transferred to the SAMS peptide per minute per milligram of protein subjected to 
immunoprecipitation (pmol/min/mg). The post-AMPK immunoprecipitation supernatants were 
then incubated in streptavidin-Sepharose high-performance beads (Amersham Biosciences) for 1 
h at 4°C for affinity purification of ACC.  
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Western blotting
The affinity-purified ACC fraction was electrophoresed on 7.5% SDS-PAGE and detected by 
immunoblotting with anti-phospho-Ser221-ACC polyclonal antibody. The blots were then stripped 
(50 mM Tris.HCl, 2% SDS, 115 mM -mercaptoethanol) at 55°C for 20 min, blocked, and 
incubated with horseradish peroxidase conjugated streptavidin (Amersham Pharmacia Biotech 
UK, Little Chalfont, UK) to determine the total ACC content. Aliquots of the 
immunoprecipitated AMPK1 and AMPK2 proteins were electrophoresed on 10% SDS-PAGE 
and detected by immunoblotting with antibodies specific for the AMPK1 and AMPK2 
isoforms. The post-AMPK immunoprecipitation supernatants containing 60 g of total protein 
were electrophoresed on SDS-PAGE [Acrylamide concentration either 15% (GLUT 4) or 10% 
(FAT CD/36, PGC1) respectively] and detected by immunoblotting with antibodies specific for 
GLUT4 (Biogenesis, UK 4670-1704), FAT/CD36 (AbCam, Cambridge, UK) or PGC-1 
(Millipore, Inc. AB3242). The immunoreactive proteins were detected with enhanced 
chemiluminescence (Amersham Biosciences) and quantified by densitometry. α-tubulin was used 
as a loading control to ensure that the protein content was the same in all wells.
3.2.5 Statistical Analysis
Data from the two experimental trials were compared by using a two-factor (diet and time) 
analysis of variance (ANOVA) with repeated measures. Separate analyses were undertaken to 
compare data from 20-min rides on day 1, 5, and 7 and data collected at different time points 
during the experimental ride. Holm-Sidak post hoc tests were undertaken when ANOVA revealed 
a significant interaction. Muscle glycogen and muscle TG concentration between trials were 
compared by using Student’s t-tests. Relationship between muscle fuel stores (muscle glycogen 
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and muscle TG) and AMPK activities were studied using Pearson product-moment correlation
coefficient. All values are expressed as means and standard error (SE) with the critical level of 
significance established at P < 0.05. 
3.3 Results
3.3.1 Substrate oxidation during exercise 
Figure 3.2A shows the rates of whole body CHO oxidation during 20-min of cycling at 70% 
VO2peak (20-min SS) on day 1, day 5 and day 7. Rates of CHO oxidation during the 20-min SS 
were similar during both trials on Day 1. There was a significant effect of diet on rates of CHO 
oxidation such that HCHO was higher than FAT-adapt at all time points after baseline (P < 0.05). 
During HCHO trial, 1 day of rest on Day 6 increased the rates of whole body CHO oxidation 
during 20-min SS significantly compared to baseline (P < 0.05). During FAT-adapt, 5 days of 
high fat diet and exercise training decreased the rates of whole body CHO oxidation such that it 
was significantly lower than all the other time points (P < 0.05).   
Figure 3.2B shows the rates of whole body fat oxidation during 20-min of cycling at 70% VO2peak
(20-min SS) on day 1, day 5 and day 7, along with the average RER data during the 1 h steady-
state ride (60-min SS) on day 7 (Figure 3.2C). Rates of fat oxidation during the 20-min SS were 
similar during both trials (P < 0.05) at baseline (Day 1). The effect of diet on rates of fat 
oxidation was significant at all time points after baseline, with FAT-adapt being higher than 
HCHO (P < 0.05). One day of high CHO diet and rest decreased rates of fat oxidation, such that 
on day 7 values were not different from day 1 (30.20 ± 3.42 vs. 25.79 ± 3.72 µmol/kg/min
respectively; P < 0.05). During HCHO, rates of fat oxidation were similar on day 1 and day 5 
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(23.03 ± 3.61 vs. 18.85 ± 2.61 µmol/kg/min; P < 0.05) but decreased on day 7 compared to day 1 
(23.03 ± 3.61 vs. 14.44 ± 1.19 µmol/kg/min; P < 0.05). The average RER over the 1 h steady 
state ride on day 7 was also lower during FAT-adapt (0.87 ± 0.004 vs. 0.93 ± 0.004; P < 0.01; 
Figure 3.2C) such that fat oxidation accounted for 40.3 ± 3.6 % of total fuel oxidation in this trial 
compared to 21.9 ± 1.5 % in HCHO (P < 0.05). 
3.3.2 Glycogen and Muscle TG
Table 3.1 displays muscle glycogen concentrations before and after the two experimental trials. 
As intended, there were no differences in pre-exercise muscle glycogen levels between dietary 
treatments (547 ± 40 and 694 ± 55 μmol/g dry wt. for FAT-adapt and HCHO respectively). 
Glycogen utilisation during 60-min SS was significantly lower after FAT-adapt (179 ± 35 vs. 264 
± 45 μmol/g dry wt., P < 0.05).
Table 3.1 Muscle glycogen concentrations before and after 1 hour steady state cycling 
at 70% of peak O2 uptake after 5 days of high fat or high carbohydrate diet followed by 1 
day of carbohydrate restoration. 
Trial Day-7 Pre-exercise Day-7 Post-exercise Utilisation
FAT-adapt 547 ± 40 369 ± 22 * 179 ± 35
HCHO 694 ± 55 460 ± 54 * 264 ± 45 §
Values are means ±SE given in μmol/g dry wt.; n ≥ 7/group. * Significantly different from 
pre-exercise, P < 0.05. § Significantly greater than FAT-adapt.
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A B
C
Figure 3.2 (A) Rates of whole body CHO oxidation estimated during 20-min of cycling at 
70% VO2peak on day 1, day 5 and during 1 h of steady state cycling at 70% VO2peak on day 7 
(B) Rates of whole-body fat oxidation estimated during 20-min of cycling at 70% VO2peak on 
day 1, day 5 and during 1 h of steady state cycling at 70% VO2peak on day 7. #, Significantly 
different from HCHO trial (P < 0.05). †, Significantly different from day 1 (P < 0.05). *, 
Significantly different from all time points within FAT-adapt (P < 0.05). (C) Average RER 
values during the 1 h steady-state ride at 70% VO2peak on day 7 (P = 0.002). Values are 
mean ± SE for 8 subjects.
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3.3.3 Muscle TG
Figure 3.3 displays muscle TG concentrations before and after 60-min steady state cycling at 
70% VO2 max. Muscle TG concentrations were higher on day 7 after FAT-adapt compared to the 
HCHO trial (69 ± 10.2 vs. 39 ± 3.4 µmol/g dry wt.; P < 0.01). Post-exercise muscle TG levels 
were similar between FAT-adapt and HCHO trial (Figure 3.3). There was a small but non-
significant increase in muscle TG concentration with HCHO after exercise. 
Figure 3.3 Muscle TG concentrations before and after exercise (60-min steady-state ride 
at 70% VO2peak) on day 7 during high carbohydrate (HCHO) and fat adaptation with 
carbohydrate restoration (FAT-adapt) trials. #, Significantly different from HCHO (P <
0.01). Values are mean ± SE; n ≥ 7/group. 
3.3.4 AMPK α1 and α2 activity 
Figure 3.4 displays resting (pre-exercise) and post-exercise AMPK signalling (AMPKα1 and α2 
activity and the phosphorylation of ACC at Ser221) after the two dietary treatments and resting 
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total protein content of AMPKα1, AMPKα2 and ACC. Resting AMPK α1 and α2 activities 
(Figure 3.4 A and B) were higher after FAT-adapt compared to HCHO (p=0.02 and p=0.05 
respectively). There were no differences in the protein content of either AMPKα1 or -α2 in 
response to either treatment (Figure 3.4C). Exercise increased AMPKα1 activity (Figure 3.4A) 
after HCHO (p=0.02) but did not have any further effects on either AMPKα1 or α2 activity after 
FAT-adapt. AMPK α1 and α2 activity post-exercise were not different between dietary 
treatments.   
There was a significant relationship (r = 0.53; P < 0.05) between resting muscle TG 
concentration and AMPKα2 activity (Figure 3.5A). When this relationship was expressed as the 
difference in resting muscle TG for each subject between the two dietary treatments versus the 
difference in AMPKα2 activity between treatment, the correlation improved to r = 0.82 (P < 0.05; 
Figure 3.5B). Resting muscle glycogen concentration was significantly associated with AMPKα1 
(r = -0.51; P < 0.05; Figure 3.5C) but not AMPKα2 activity. There was a trend for a relationship 
between muscle TG utilisation and changes in AMPKα2 activity (r = 0.52; P = 0.06; Figure 3.5D) 
but no relationship between muscle TG utilisation and AMPKα1 activity. 
3.3.5 Phosphorylation of ACC at Ser221 (pACC Ser221) 
The phosphorylation of the AMPK downstream target ACC at Ser221 (relative to total protein 
content) on day 7 tended to be higher at rest after FAT-adapt compared to HCHO (P = 0.09). 
Exercise increased the pACC Ser221 during both HCHO (P = 0.042) and FAT-adapt (P = 0.008) 
with the post-exercise pACC Ser221 being higher during the FAT-adapt compared to the HCHO 
trial (P = 0.02; Figure 3.4D).
67
A AMPKα1 activity B AMPKα2 activity
C Resting total protein content D pACC/Total ACC
Figure 3.4 AMPK signalling before and after exercise on day 7 during high 
carbohydrate (HCHO) and fat adaptation with carbohydrate restoration (FAT-adapt)
trials. (A) AMPK α1 activity, (B) AMPK α2 activity, (C) Relative levels of resting (pre-
exercise) total protein content of AMPK α1, AMPK α2 and ACC as quantified by western 
blot analysis and densitometry, (D) Phosphorylation of ACC at Serine 221 relative to total 
ACC protein content (pACC Ser221). Significant differences between groups (P < 0.05) are 
indicated by the P values listed on the figure. Values are mean ± SE for 8 subjects.
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A    B
C    D
Figure 3.5 Scatter plots showing the relationship between (A); resting muscle 
triglyceride concentration and resting AMPKα2 activity (n = 14); (B) Differences in resting 
muscle triglyceride concentration and differences in resting AMPKα2 activity between 
trials (n = 6 pairs); (C) resting muscle glycogen concentration and resting AMPKα1 activity
(n = 15) between trials; (D) Changes in AMPKα2 activity during exercise and muscle TG 
utilisation during exercise (n = 7 pairs).
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3.3.6 Protein expression
Total protein abundance for FAT/CD36, GLUT 4 and PGC1 were not different between trials
(Figure 3.6).
Figure 3.6 Representative western blots showing total protein concentration for 
FAT/CD36, GLUT4 and PGC1 before (pre) and after (post) exercise on day 7 during 
HCHO and FAT- adapt trials.
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3.4 Discussion
This study used a human model of short-term (5 days) adaptation to a high-fat diet followed by 1 
day of carbohydrate restoration (i.e., a high carbohydrate diet) in well-trained athletes 
undertaking high-volume, intense training to study the effects of diet-exercise interactions on 
muscle signalling and metabolism. The novel findings from the present study were that despite 
the brevity of the intervention period, 1) the FAT-adapt protocol resulted in elevated resting 
muscle triglyceride concentrations that were independent of glycogen availability, 2) changes in 
muscle triglyceride levels were associated with increased basal AMPK activity without 
concomitant changes in protein levels, and 3) FAT-adapt attenuated the exercise-induced rise in 
AMPKα1 and AMPKα2 activity compared to an isoenergetic high carbohydrate diet.
In accordance with previous investigations (Burke, et al., 2000; Burke, et al., 2002; Carey, et al., 
2001; Stellingwerff, et al., 2006), this study again report that rates of fat oxidation during 60 min 
of submaximal cycling (70% of VO2peak) were elevated ~2-fold after fat adaptation followed by 
carbohydrate restoration compared to when subjects performed identical training and consumed 
an isoenergetic high carbohydrate diet throughout the 6 day intervention period (Figure 3.2). 
Furthermore, muscle glycogen utilisation was significantly lower after FAT-adapt (Table 3.1). In 
several earlier studies performed utilising similar dietary perodization model (Burke, et al., 2000; 
Burke, et al., 2002; Carey, et al., 2001; Stellingwerff, et al., 2006), it was not clear what 
metabolic signal(s) accounted for the shift in muscle substrate use during exercise. The results of 
the present study show that one of the residual effects of the short-term high-fat diet was to 
increase resting muscle TG stores (Figure 3.3). The resting TG levels observed in these well-
trained athletes after just 5 d of consuming a high-fat diet are in close agreement with those 
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reported by Helge et al. (2002) for previously untrained subjects who completed 7 wk of 
endurance training while consuming a high-fat diet (Helge, et al., 2002). They are also similar to 
the values of Zderic et al. (2004) for endurance-trained cyclists after 2 d of a high-fat diet and
Zehnder et al. (2006) in muscle from trained athletes after just 1.5 days of lipid supplementation 
(Zehnder, et al., 2006). Taken collectively, these findings suggest that muscle TG stores are prone 
to rapid fluctuations in response to changes in nutrient composition and physical activity levels. 
In one of the previous studies (Cameron-Smith, et al., 2003), it was shown that 5 days of a high-
fat diet coupled with a rigorous training programme resulted in a small (17%) but significant 
increase in the protein abundance of fatty acid translocase (FAT/CD36). These data (Cameron-
Smith, et al., 2003) indicated that an increase in dietary lipid availability was, in part, responsible 
for the rapid up-regulation of FAT/CD36 protein expression, suggesting a role for this FA 
transporter in facilitating greater skeletal muscle FA uptake.  In that investigation, the effects of 5 
d of a high-fat diet on FAT/CD36 was examined without a 1-day carbohydrate restoration phase. 
In the present study, FAT/CD36 protein content was measured after fat adaptation followed by 1 
day of rest and a high carbohydrate diet. Under these dietary conditions, there were no differences 
in the abundance of this FA transporter detected between the fat adaptation protocol and the high 
carbohydrate diet intervention. To the best of our knowledge, no previous studies have measured 
GLUT4 or PGC1 protein expression in response to the short-term fat adaptation and carbohydrate 
restoration protocol utilised in the present study. However, Steinberg et al. (2006) reported higher 
skeletal muscle GLUT4 mRNA expression immediately after an acute bout of endurance exercise 
commenced with low (versus normal) glycogen content. With regard to PGC1, Sparks et al. 
(Sparks, et al., 2005) reported that PGC1α mRNA was reduced by 20% in muscle from healthy 
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young males following 3 days of a high fat diet, whereas Mortensen et al. (2007) found no 
differences in PGC-1α mRNA expression after a chronic training intervention in previously 
untrained subjects in which 50% of the training sessions were performed under conditions of low 
starting muscle glycogen concentration.
A second important finding from the present study was that the high-fat diet was accompanied by 
increased AMPK1 and 2 activity (Figure 3.4, Panels A and B). Wojtaszewski et al. (2003)
have also demonstrated that resting AMPK activity is sensitive to fuel status (Wojtaszewski, et al., 
2003).  These workers reported that AMPK activities for both 1 and 2 isoforms were higher in 
the face of low- (~160 mmol/kg dry wt.) compared to high- (~900 mmol/kg dry wt.) resting 
muscle glycogen content. While their results (Wojtaszewski, et al., 2003) suggest a relationship 
between muscle glycogen content and AMPK activity, it is unlikely that altered muscle glycogen 
availability is the only factor regulating muscle AMPK activity. The diet-exercise intervention 
used to differentiate resting muscle glycogen stores in the study of Wojtaszewski et al. (2003) is 
also likely to have resulted in elevated muscle triacylglycerol levels, particularly as arterial 
plasma FFA concentrations were significantly higher in the low- versus high-glycogen condition. 
Although plasma FA levels were not measured in the current investigation, it’s concentrations at 
rest has previously been shown to be similar between the two diet interventions (Burke, et al., 
2000; Burke, et al., 2002; Carey, et al., 2001). 
A recent study reported that AMPKα2 but not -1 activity was increased in rodent skeletal 
muscle in response to chronic high-fat feeding (Lessard, et al., 2007). Of note in that study was 
the observation that AMPKα1 activity was only increased in high fat-fed rodents when they 
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concurrently undertook an intense endurance training programme with a high-fat diet (Lessard, et 
al., 2007).  At the time Lessard et al. (2007) suggested that there may be distinct roles for the 
AMPK -α subunit isoforms in skeletal muscle, with AMPKα1 activity being linked to exercise 
training-induced adaptations and muscle glycogen storage and AMPKα2 activity being 
responsive to increased lipid availability (Lessard, et al., 2007). The present study provides 
further data in support of this premise. A significant relationship between resting AMPKα1 
activity (but not -2) and muscle glycogen content (r = -0.51, P < 0.05) was observed. In contrast, 
AMPKα2 (but not α1 activity) was positively associated with resting muscle triglyceride content 
(r = 0.53, P < 0.05). Perhaps the most robust evidence to corroborate the isoform-specific 
modification of resting AMPK activity and muscle lipid status comes from the paired data from 
each subject’s resting biopsy samples: compared to a high carbohydrate diet, fat adaptation 
significantly increased muscle triglyceride concentration (Figure 3.3), with such changes being 
strongly correlated to difference in basal AMPK2 activity (r = 0.82, p<0.05). Raney and 
Turcotte (2006) have also reported a positive association between fatty acid uptake and oxidation 
and AMPK2 activity in the perfused rat hindlimb model. However, it should be noted that 
correlational data cannot determine causality and it is possible that factors other than muscle lipid 
status may play a role in modifying AMPKα2 activity. In this regard, while resting muscle 
glycogen concentrations were not statistically significant between the two dietary groups, values 
in the high-carbohydrate trial were, on average, 27% higher than after the high-fat diet. It is well 
accepted that pre-exercise muscle glycogen availability influences subsequent rates of muscle 
glycogenolysis (Hargreaves, et al., 1995; Hargreaves and Richter, 1988). Indeed, it is likely that a 
25-30% difference in resting glycogen content is of physiological significance (Hargreaves, et al., 
1995).
74
While it is tempting to attribute a causal role for altered muscle substrate availability (i.e. 
glycogen and/or triglyceride stores) on subsequent changes in AMPK signalling, it should be 
acknowledged that differences in AMPK responses in the present study could, in part, be due to 
the well-trained subjects performing prolonged, strenuous training on a high-fat diet (i.e., the 
interactive effects of diet and exercise). In this regard, Hansen et al. (2005) have previously 
reported that compared to daily training with normal glycogen reserves, commencing 50% 
training sessions with low muscle glycogen (and presumably higher triglyceride) levels resulted 
in a more pronounced increase in citrate synthase activity. The potential mechanism(s) for this 
augmented training response after ‘low glycogen’ training is hard to define, but it is possible that 
commencing exercise with reduced glycogen (i.e. high-fat) availability may promote training 
adaptations through perturbation in circulating systemic factors (i.e. increased catecholamines), 
altered muscle substrate availability or a combination of both. Although catecholamine levels 
were not measured during training in the present study, Hansen et al. (2005) have reported that 
the catecholamine response to exercise performed with low muscle glycogen levels are higher 
than when exercise undertaken with normal glycogen stores, demonstrating a higher stress 
response. Further work will be needed to determine the precise roles of local (muscle) versus 
systemic factors in modifying AMPK responses to diet/exercise manipulations.  
As noted previously, one of the residual effects of 5 d of a high-fat diet in combination with 
intense training is that rates of whole-body fat oxidation during submaximal exercise remain 
elevated above those observed after a high carbohydrate diet, even when carbohydrate stores are 
restored (Burke, et al., 2000; Carey, et al., 2001; Stellingwerff, et al., 2006). Accordingly, one 
would predict that the pattern of activation of the downstream target of AMPK, ACCβ would 
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reflect such perturbations. This is indeed the case. pACCβ Ser221 tended to be higher at rest after 
fat adaptation compared to the high carbohydrate diet (P = 0.09, Figure 3.4 D), and while there 
was an exercise-induced increase in pACC Ser221 for both treatments, the phosphorylation state 
of ACCβ Ser221 was significantly higher at the end of exercise after fat adaptation (P = 0.02; 
Figure 3.4 D). Wojtaszewski et al. (2003) have previously reported that resting ACCβ Ser221
phosphorylation was higher in subjects with low- compared to high resting muscle glycogen 
stores. In that study (Wojtaszewski, et al., 2003) concentrations of creatine phosphate and 
adenine nucleotides in resting and exercised muscles were not altered by the glycogen 
manipulation leading these workers to suggest that in basal conditions at least, fuel-dependent 
mechanisms independent of energy status may regulate AMPK signalling. Due to insufficient 
muscle sample in the present investigation, high-energy phosphate contents and muscle 
metabolites could not be measured, but using the identical diet-exercise regimen and subjects of 
comparable training status, similar resting values for muscle adenine nucleotides was reported by
Stellingwerff et al. (2006).  However, in contrast to the findings of Wojtaszewski et al. (2003), 
Stellingwerff et al. (2006) found that after 20 min of cycling at the same intensity as employed in 
the current study, fat adaptation was associated with a lower accumulation of free ADP and AMP 
after 20 min of submaximal exercise compared to the high carbohydrate intervention 
(Stellingwerff, et al., 2006). 
In conclusion, the present study used a human model of ‘dietary periodisation’ (i.e., fat 
adaptation followed by carbohydrate restoration) to study the interactive effects of alterations in 
fuel availability (i.e. muscle lipid stores) and exercise training on AMPK signalling and 
metabolism. It was found that, compared to an isoenergetic carbohydrate diet for 6 d, 5 d of a 
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high-fat diet followed by 1 d of rest and a high carbohydrate diet resulted in higher resting muscle 
triglyceride levels. The altered muscle fuel status at rest was associated with increased AMPKα1 
and α2 activity. During exercise, FAT-adapt increased rates of whole-body fat oxidation and 
‘spared’ muscle glycogen. Accordingly, the increase in ACCβ Ser221 phosphorylation was greater 
after fat adaptation compared to the high carbohydrate diet. The changes in AMPK activation 
observed in the present study could be due to altered fuel status (increased muscle lipid 
availability), a greater adaptive response when training with low muscle glycogen availability, or 
most likely, the interactive effects of both these factors.
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Chapter Four
Skeletal muscle adaptation and performance responses to once a 
day versus twice every second day endurance training regimens
Adapted from: Yeo WK, Paton CD, Garnham AP, Burke LM, Carey AL, Hawley JA.
Journal of Applied Physiology 105(5):1462-70
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4.1 Introduction 
Training capacity (the ability to complete strenuous training sessions over days and weeks) and 
nutrition are highly interrelated and it is generally assumed that optimal adaptation to the 
demands of repeated training sessions requires a diet that can sustain muscle energy reserves 
(Burke, 2003; Coyle, 2000). However, evidence is accumulating to suggest that commencing 
endurance exercise with low muscle glycogen content increases the transcription rate of several 
genes and proteins involved in the training response/adaptation (Febbraio, et al., 2002; Furuyama, 
et al., 2003; Keller, et al., 2001; Pilegaard, et al., 2002; Steinberg, et al., 2006; Wojtaszewski, et 
al., 2003). Indeed, in recent years it has become evident that commencing exercise in the face of 
low muscle glycogen stores amplifies the activation of a number of signalling proteins, including 
the AMP-activated protein kinase (AMPK) and the p38 mitogen-activated protein kinase 
(MAPK), two enzymes with direct roles in controlling the expression and activity of several 
transcription factors involved in mitochondrial biogenesis and promoting training adaptation [for 
review see Baar and McGee (2008), Hawley et al. (2006)]. Accordingly, the notion that 
commencing training with low muscle glycogen levels (‘train-low’) to maximize the 
physiological response/adaptation to endurance training has gained popularity (Baar and McGee, 
2008).  
Only one study has tested the hypothesis that undertaking a training programme in which a 
portion of exercise sessions are deliberately commenced with low muscle glycogen may be 
beneficial for training adaptation and subsequent performance. In that investigation, Hansen et al. 
(2005) recruited 7 untrained males to undertake a 10 wk programme of leg knee extensor 
‘kicking’ exercise. In an ingenious experimental design, both of the subject’s legs were trained 
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according to a different daily schedule but the total amount of work undertaken by each leg over 
the study duration was the same: subjects trained one leg twice-a-day, every second day, whereas 
the contra lateral leg was trained daily. Compared to the leg that performed daily training with 
normal glycogen reserves, the leg that commenced half of the training sessions with low muscle 
glycogen levels had a more pronounced increase in resting glycogen content and citrate synthase 
activity (Hansen, et al., 2005).  Remarkably, this ‘train-low’ approach resulted in an almost two-
fold greater training-induced increase in one-leg exercise time to fatigue compared to when 
participants commenced all training sessions in a glycogen replete state. The results of Hansen et 
al. (2005) demonstrate that under specific experimental conditions, training adaptation may be 
augmented by a relative lack of glycogen availability and this, in turn, leads to an enhancement in 
endurance. 
While the results of that study (Hansen, et al., 2005) are intriguing, several issues currently 
preclude exercise scientists from making firm recommendations to athletes with respect to 
undertaking endurance training for performance enhancement in a low glycogen state. First, the 
subjects in the investigation of Hansen et al. (2005) were untrained and it is not currently 
known whether undertaking training sessions in a lowered glycogen state will translate into 
improved training adaptation and performance in already well-trained athletes. Second, the 
training sessions undertaken by subjects in that study were ‘clamped’ at a fixed submaximal 
intensity for the duration of the training programme: athletes typically periodise their 
programmes to incorporate a ‘hard-easy’ pattern to the overall organization of training, as well 
as progressive overload (Hawley and Stepto, 2001; Stellingwerff, et al., 2007a) rather than 
training to a fixed (submaximal) intensity. Third, the mode of training (one-legged knee 
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extensor kicking) and the exercise ‘performance’ task (submaximal kicking to exhaustion) bear 
little resemblance to the whole-body training modes and performance tasks undertaken by the 
majority of competitive athletes. Fourth, training schedules that induce chronically low muscle 
glycogen levels may increase the risk for the overtraining syndrome (Petibois, et al., 2003) and 
actually lead to a reduced training capacity (Achten, et al., 2004). Finally, the vast majority of 
athletes are reluctant to take complete rest days, and training every second day would be 
considered an extreme practice amongst this cohort. Accordingly, the aims of the present study 
were to determine the effects of undertaking selected training sessions with low muscle 
glycogen content on 1) training capacity and endurance performance, 2) whole-body substrate 
metabolism during submaximal exercise and 3) several mitochondrial enzymes and signalling
proteins with putative roles in promoting training adaptation. Well-trained subjects were 
selected for this investigation: it was hypothesised that these athletes would already have 
maximised their training adaptation and that further gains would be minimal, irrespective of 
whether they trained with low or normal levels of muscle glycogen.
4.2 Methods
4.2.1 Subjects and preliminary testing
Eighteen endurance-trained male cyclists or triathletes volunteered to participate in this study 
after they were informed about the possible risks of all procedures. All subjects gave written 
consent. This study was approved by the RMIT University Human Research Ethics Committee. 
Of the eighteen subjects (Table 4.1), 14 took part in the chronic training study while 12 subjects 
(which included 8 subjects from the chronic study plus an additional 4 subjects who met the same 
criteria for age, fitness level and training history) participated in the acute phase of the 
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investigation (described in detail subsequently). In the 6 wk prior to commencement of the study, 
subjects were riding 300-500 km/wk but were not undertaking any interval training. Subjects had 
a history of > 3 yr of endurance-based training. One week prior to an experimental testing session, 
each subject undertook an incremental cycling test to exhaustion on an electromagnetically 
braked cycle ergometer (Lode, Groningen, The Netherlands). The testing protocol has been 
described in previous study in Chapter 3 and was originally used in Hawley and Noakes (1992). 
During the maximal test and the subsequently described experimental trials, subjects breathed 
through a Hans Rudolph two way non-rebreathing valve and mouthpiece attached to a calibrated 
online gas system (Parvomedics, Utah, U.S.A) interfaced to a computer, that calculated the 
instantaneous rates of O2 consumption (VO2), CO2 production (VCO2), minute ventilation 
(VESTPD), and the respiratory exchange ratio (RER) every 15 s from conventional equations 
(Péronnet and Massicotte, 1991). Before each maximal test and all experimental trials, the 
analysers were calibrated with commercially available gases of known O2 and CO2 content. Peak 
VO2 was defined as the highest O2 uptake a subject attained during any 60 s of the test while PPO 
was calculated from the last completed work rate plus the fraction of time spent in the final 
noncompleted work rate multiplied by 25 W. This value was used to determine the power output 
corresponding to 70% of each subject’s VO2peak (63% of PPO) to be used in the subsequently 
described experimental trials and training sessions. The maximal test and all experimental trials 
were conducted under standard laboratory condition (18-22ºC, 40-50% relative humidity) and 
subjects were fan cooled during all exercise sessions.    
82
Table 4.1. Characteristics of the subjects that participated in the 3-wk chronic training 
study and the acute study. PPO, Peak sustained power output. Values are means ± SE.
Subject characteristics
Age 
(yr)
Body Mass 
(kg)
VO2peak
(L∙min-1)
PPO
(W)
Chronic study (n=14)     30.0 ± 1.8 77.7 ± 2.7 4.7 ± 0.1 382.1 ± 9.3
Acute study (n=12) 28.1 ± 2.0 77.4 ± 3.3 4.7 ± 0.2 365.5 ± 7.9
4.2.2 Experimental Design
An overview of the experimental design is shown in Figure 4.1. In brief, the subjects were 
divided into two groups (matched for age, VO2 peak and training history) and undertook 18 
laboratory training sessions during a 3 wk intervention period. The control group (HIGH) trained 
6 days per week (rest on day-7) for 3 wk, alternating between 100-min steady state aerobic 
training (AT; ~70% VO2 peak, 63% of PPO) on the first day and high intensity interval training 
(HIT; 8 x 5-min work bouts at maximal effort with 1-min recovery in between work bouts at 
100W) the next day. In contrast, the experimental group (LOW) trained twice per day, every 
second day, performing the AT in the morning, followed by 1-2 hr of rest and then HIT (Figure 
4.1). During the time between these two training sessions, subjects rested in the lab and were 
given ad libitum access to water. Subjects groups were designated as HIGH or LOW: HIGH 
completed all HIT sessions at a time when muscle glycogen levels were restored whereas LOW 
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undertook these HIT sessions at a time when muscle glycogen stores were partially depleted, or 
lower than normal. Accordingly, the 100-min AT was used in this study because it has previously 
been reported that endurance-trained cyclists comparable in training status to those in the current 
investigation utilised ~60% of their muscle glycogen content after 105 min of steady-state 
cycling at ~70% of individual VO2peak (Coyle, et al., 1986). The HIT session utilised in this study 
has been described in detail previously (Stepto, et al., 2001). In brief, this training session 
involves 8 repetitions of 5-min work bouts at ~75-80% of PPO, separated by 1 min of recovery at 
≤ 100W. It has been previously reported that this workout utilizes ~50% of muscle glycogen 
stores when the session is commenced with normal glycogen content (~500 mol/g dry wt.) 
(Stepto, et al., 2001). All the training sessions were performed using the subject’s own bicycle 
attached to a stationary trainer (Kinetic, MN, USA) and training intensities were monitored using 
PowerTap power meters (CycleOps, Madison, USA). Before every training session, the 
PowerTap was zeroed according to the manufacturer’s instructions. These devices have 
previously been shown as a valid and reliable tool to accurately monitor power output in both lab 
and field settings (Bertucci, et al., 2005; Gardner, et al., 2004; Paton and Hopkins, 2006). All HIT 
sessions in the HIGH group and all training sessions in the LOW group were performed in the 
laboratory under supervision of the principal investigator. Subjects in the HIGH group performed 
their AT at home on an indoor stationary trainer. Power output for all these sessions were 
recorded to ensure that the subjects trained at the prescribed intensity (63% PPO) and for the 
required duration (100 min). 
84
Figure 4.1. Overview of the study design and experimental trial. , AT, Aerobic training.  
, HIT, High intensity interval training.  R, Rest. Ex. Trial, experimental trial.
4.2.3 Dietary control
The goal of the present study was to provide a similar dietary treatment to that received by 
subjects in the Hansen et al. (2005) study.  A variety of methods were used to achieve this in this 
group of free-living subjects. Dietary intake was ‘clamped’ 24 hr prior to an experimental trial 
(0.21 MJ/kg BM; 8 g/kg/d and 65% of energy from CHO; 2.0 g/kg/d protein and 1.0 g/kg/d fat). 
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All meals and snacks were supplied with diets being individualized for food preferences and BM. 
Subjects received their food in pre-prepared packages and were required to keep a food checklist 
to note their compliance to the dietary instructions and their intake of any additional food or 
drinks. This method was also used during the day(s) preceding the training sessions that were 
chosen for examination of the acute response to exercise (see below). During the remainder of the 
training period, subjects were given dietary instructions by a sports dietician, including sample 
diets and check-lists of carbohydrate-rich foods to ensure that they were consuming 8-9 g/kg/d 
BM of CHO. Every 2 days, subjects were required to submit records of their dietary intake and 
morning BM to the sports dietician to ensure adherence to carbohydrate intake targets and to fine 
tune energy intake to maintain energy balance.
4.2.4 Acute responses to AT and HIT sessions
Twelve subjects (including 8 from the experiments described previously and 4 additional subjects 
who met the same criteria for age, VO2peak and training history) gave their informed consent to 
complete one session of AT and one session of HIT according to the training schedule for their 
designated group. One week prior to the commencement of a training session, the 4 additional
recruits reported to the laboratory to complete preliminary testing (described previously). 
Subjects were rested and provided with packaged diets (described above) for the 24 hr prior to 
these training sessions. Subjects performed the training sessions on their own bikes attached to a 
stationary trainer with power meters attached (described previously). On arrival in the laboratory, 
a single leg was prepared for skeletal muscle biopsy sampling through two incisions 2–3 cm apart 
along the vastus lateralis muscle. A resting muscle sample was then taken using the percutaneous 
biopsy technique with suction applied while a second biopsy was obtained immediately before 
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the HIT. All muscle biopsies were rapidly frozen in liquid N2 within ~15 s and stored at -80ºC 
and later analysed for muscle glycogen content. In the case of the subjects who were concurrently 
involved in the chronic training study, these invasive sessions were performed mid-way through 
the 3 wk training programme (Figure 4.3).
4.2.5 Experimental trial
Forty-eight hr before the first training session and 48 hr after the last training session, subjects 
reported to the laboratory after a 12- to 14-h overnight fast to undertake an experimental trial 
comprising of a 60-min steady state ride at 70% of VO2peak (60SS) followed by a 60-min 
performance trial. Skeletal muscle biopsies (described previously) were performed at rest upon 
subjects’ arrival in the laboratory and immediately after the 60SS. The subjects were given 10 
min of rest after the resting biopsy before began the 60SS and after 10, 30 and 50 min, expired 
gas was collected (for 5-min) to estimate the instantaneous rates of substrate oxidation. Fifteen 
min after the completion of 60SS, the subjects began the performance ride. Endurance 
performance was determined as the average power maintained (W/kg BM) during the 60-min 
period.
4.2.6 Analytical Procedures
Rates of whole body fat oxidation. 
Rates of whole body fat oxidation (g/min) were calculated from the RER data collected for 5 min 
at 10, 30 and 50 min of the 60SS. The calculations were made from VCO2 and VO2
measurements, assuming a nonprotein RER value, according to the following equation (Péronnet 
and Massicotte, 1991).
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Fat oxidation = 1.695 VO2 - 1.701 VCO2
Rates of fatty acid oxidation (mol/kg/min) were determined by converting the rate of triglycerol 
oxidation (g/min) to its molar equivalent assuming the average molecular weight of human 
triglycerol to be 855.3 g/mol and multiplying the molar rate of triglycerol oxidation by 3, because 
each molecule contains three molecules of fatty acids. Total fat oxidation during the 60SS was 
estimated by calculating the area under the oxidation versus time curves for each subject.
Muscle glycogen concentration
Approximately 10-15 mg of muscle was freeze-dried and powdered with all visible blood and 
connective tissue removed under magnification. The freeze-dried muscle sample was then 
incubated in 250 µL of 2 M hydrochloric acid at 100 ºC for 2 hr before being neutralized with 
750 µL of 0.67 M sodium hydroxide. Glycogen concentration was determined via enzymatic 
analyses (50 mM Tris, 25 mM HCL, 1 mM MgCl2, 0.5 mM DTT, 0.3 mM ATP, 0.05 mM NADP 
and 1 U/ml HK, 0.1 U/ml G-6-PDH) with glucose standards by fluorometric detection and was 
expressed as micromoles of glycogen/g dry wt. 
Citrate synthase and -hydroxyacyl-CoA dehydrogenase activity. 
Freeze-dried, powdered muscle (2-3 mg) was homogenised in 100 mM potassium phosphate 
buffer (pH 7.3, 1:400 dilution), and citrate synthase was assayed spectrophotometrically at 25ºC 
by the reduction of DNTB, as published previously (Srere, 1969) with slight modifications 
(Bruce, et al., 2003). -hydroxyacyl-CoA dehydrogenase (-HAD) activity was assayed 
spectrophotometrically at 25ºC using the same homogenates, based on the disappearance of 
reduced NADH (Lowry and Passonneau, 1972).
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Western blotting
Approximately 30 mg of wet muscle was homogenised (50 mM Tris HCl, pH 7.5, 1 mM EDTA, 
1 mM EGTA, 1 mM dithiothreitol, 50 mM NaF, 5 mM Na pyrophosphate, 10% glycerol, 1% 
Triton X-100, 10 µg/ml trypsin inhibitor, 2 µg/ml aprotinin, 1 mM benzamidine, and 1 mM 
phenylmethylsulfonyl fluoride) and the homogenates were then centrifuged at 20,000 g for 30 
min at 4ºC.  The supernatant was aliquoted and stored at -80ºC until further analysis. The total 
protein concentration in the aliquots was determined by the bicinchoninic acid method (Pierce, IL, 
USA). 
Muscle lysates containing 60 g (pAMPKThr172, Total AMPK and PGC-1α) and 30 g 
[Cytochrome C oxidase subunit II and IV (COX II and COX IV respectively)] of total protein 
were electrophoresed on 10% (pAMPKThr172, Total AMPK and PGC-1α) and 14% (COX II and 
COX IV) SDS-PAGE and detected by immunoblotting with antibodies specific for PGC-1
(Santa Cruz Biotechnology, Santa Cruz, CA; sc13067), -tubulin (Cell Signalling, Danvers, MA; 
#2144), pAMPKThr172 and Total AMPK (a gift from Professor Bruce Kemp), COX II 
(Mitosciences, Oregon; MS 405) and COX IV (Mitosciences, Oregon; MS 407). Since most 
analyses required completion of multiple gels due to the large number of samples, an identical 
internal standardised human skeletal muscle sample, designated “Control”, was used in all gels to 
account for variability between exposures of different membranes. PGC-1, COX II and COX IV
protein content was expressed relative to total α-tubulin, whereas pAMPKThr172 was expressed 
relative to total AMPK. The immunoreactive proteins were detected with enhanced 
chemiluminescence (Amersham Biosciences) on a BioRad Chemidoc XRS system (BioRad, CA) 
and quantified by densitometry (Quantity one, BioRad, CA).
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Mitochonrial DNA determination 
Mitochondrial DNA (mtDNA) was quantified by real-time PCR using methods described 
previously (Menshikova, et al., 2005), with modification and optimisation to allow multiplex 
PCR. Briefly, total mitochondrial and nuclear DNA was isolated from ~20 mg of snap-frozen 
muscle tissue using a commercially available kit (Qiagen, Victoria, Australia), and the 
concentration of each sample was determined using a Nanodrop ND-1000 spectrophotometer 
(ThermoFisher Scientific, DE, USA). Ten ng of DNA from each sample was amplified in a 
BioRad iCycler PCR detection system using BioRad iQ Supermix (BioRad, NSW, Australia), 
900 nM of forward and reverse primers for mtDNA and -globin as a housekeeping gene (Sigma 
Genosys, NSW, Australia), and 225 nM of FAM-labelled Taqman probe for mtDNA and VIC-
labelled probe for -globin (Applied Biosystems, Victoria, Australia). Reaction volume was 25 
l, and primer and probe sequences were as previously reported (Menshikova, et al., 2005). Data 
were quantified using the delta-Ct method to quantitate fold changes in mtDNA compared to pre-
training values.
Statistical Analysis
Treatment effects were analysed using two-factor (treatment and time) repeated measure analysis 
of variance (ANOVA) with post-hoc analysis performed using the Holm-Sidak method. Data 
were analysed using SigmaStat 3.1.1 (Systat Software, Inc., CA) and all values are expressed as 
means ± standard error (SE), with significance reported as p<0.05. 
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4.3 Results
4.3.1 Muscle glycogen concentration before AT and HIT training sessions
Figure 4.2 displays muscle glycogen content before AT and HIT in the subgroup of 12 subjects 
who participated in the acute phase of the study. As intended, muscle glycogen stores in HIGH 
were similar before both AT and HIT (~400 mol/g dry wt.). In LOW, however, muscle 
glycogen stores were significantly reduced after AT (P < 0.05, Figure 4.2) such that LOW 
commenced the HIT with ~50 % less glycogen than before the AT. 
Figure 4.2. Muscle glycogen concentration before aerobic training (AT) and before high 
intensity interval training (HIT) during the acute training study. * Significantly different 
from Pre-AT (P < 0.05). Values are mean ± SE; n ≥ 6/group. 
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4.3.2 Training intensity during HIT
During week 1 (HIT 1-3), LOW trained at a significantly lower average percentage of PPO 
compared to HIGH (P < 0.05, Figure 4.3). During the second week (HIT sessions 4-6) of 
intervention, there was a strong trend for the average training intensity to be lower (P = 0.06, 
Figure 4.3) but by the third week (HIT sessions 7-9), the average training intensities between 
LOW and HIGH were not different (Figure 4.3). 
Figure 4.3. Training intensity expressed as percentage of peak power output (PPO) 
during HIT sessions. * Significantly different between HIGH and LOW (P < 0.05);               
n = 7/group.
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4.3.3 Resting muscle glycogen concentration
After 3 wk of training, resting muscle glycogen concentration increased significantly from 412 
51 mol/g dry wt. to 577  34 mol/g dry wt. (P < 0.05, Figure 4.4) in LOW. While glycogen 
levels increased in HIGH, such changes failed to reach statistical significance.
Figure 4.4 Resting muscle glycogen concentration before and after the 3-week training 
intervention. * Significantly different from Pre-training (P < 0.05). Values are mean ± SE;
n ≥ 6/group. 
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4.3.4 Fat oxidation during 60-min steady-state ride
Estimated rates of fat oxidation during the 60SS after 10, 30 and 50 min of the ride are shown in 
Figure 4.5. Fat oxidation during the 60SS, measured as the total area under the fat oxidation vs. 
time curve (AUC) showed a strong trend (P = 0.051) to be greater in LOW after the 3 wk training 
period (1698  174 vs. 1261  247 mol/kg/60 min). The AUC measured as the last 40 min of 
the 60SS was significantly greater in LOW after training (1220  100 vs. 867  166 mol/kg/40 
min, P < 0.05).
Figure 4.5 Rates of whole-body fat oxidation at 10, 30 and 50 min before (Pre) and after 
(Post) the 3-week training intervention. * Significantly different from Pre-training (P <
0.05). Values are mean ± SE; n = 7/group. 
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4.3.5 Citrate Synthase and -HAD activity
Maximal citrate synthase activity in LOW increased from 45  2 mmol/kg/min dry wt. to 54  1 
mmol/kg/min dry wt. (Figure 4.6A; P < 0.05) after the 3 wk training period such that the post-
training maximal activity in LOW was significantly higher than the post-training maximal 
activity in HIGH (Figure 4.6A; P < 0.05). The maximal citrate synthase activity remained 
unchanged in HIGH (39  5 mmol/kg/min dry wt. to 43  3 mmol/kg/min dry wt., Figure 4.6A) 
after the 3 wk training period. 
-HAD activity increased in LOW (18  2 mmol/kg/min dry wt. to 23  2 mmol/kg/min dry wt.; 
P < 0.05; Figure 4.6B) such that the post-training maximal activity in LOW was significantly 
higher than the similar time point in HIGH (Figure 4.6B; P < 0.05). The maximal -HAD activity 
remained unchanged in HIGH after the 3 wk training period (16  1 mmol/kg/min dry wt. to 17 
1 mmol/kg/min dry wt.).
4.3.6 Cytochrome c oxidase subunits II and IV
The total protein content of COX II (relative to total α-tubulin content) remained unchanged after 
the 3-wk training intervention in both groups (Figure 4.6C). However, the total protein content of 
COX IV (relative to total α-tubulin content) was significantly higher only in LOW after the 3-wk 
training intervention (P < 0.05, Figure 4.6D).
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A B
C D
Figure 4.6 (A) Maximal citrate synthase activity, (B) Maximal β-hydroxyacyl-CoA-
dehydrogenase activity, (C) Total protein content of cytochrome c oxidase subunit II, and
(D) Total protein content of cytochrome c oxidase subunit IV before (Pre) and after (Post) 
the 3-week training programme. * Significantly different compared to LOW-Pre-training 
(P < 0.05). # Significantly different compared to HIGH-Post-training (P < 0.05). Values are 
mean ± SE; n = 7/group.   
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4.3.7 Mitochondrial DNA
There was no effect of either training programme on skeletal muscle mtDNA content after the 3 
wk training interventions (Figure 4.7). 
Figure 4.7 Mitochondrial DNA content before (Pre) and after (Post) the 3-week training 
programme. Values are mean ± SE. n = 7/group. 
4.3.8 pAMPKThr172 and PGC1α    
Phosphorylation of AMPK at threonine-172 measured in skeletal muscle biopsy samples was 
unchanged after 1 hr of submaximal cycling both before and after training (Figure 4.8A). 
Total protein content of PGC-1 (relative to total α-tubulin) content was also unchanged after the 
3-wk training intervention (Figure 4.8B).
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Figure 4.8 Representative western blots for (A) phosphorylation of AMPK at threonine-
172 and total AMPK at rest and after exercise, before (Pre) and after (Post) 3-week training 
intervention, and (B) Resting total peroxisome proliferator-activated receptor gamma 
coactivators-1α (PGC-1α) and α-tubulin protein content before (Pre) and after (Post) 3-wk 
training intervention. Exerc, Exercise. Control, standardised protein sample loaded to 
account for variation between membranes.  
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4.3.9 Endurance performance
Figure 4.9 displays the average power output (corrected for BM) maintained during the 60-min 
performance trial before and after the 3-wk training intervention, along with individual changes 
for each subject. After the 3 wk training intervention, performance during the 60-min time trial 
was significantly higher for both groups (12.2  2.3 % vs. 10.2  3.1 % for LOW and HIGH 
respectively, P < 0.01; Figure 4.9). The magnitude of increase in performance was not different 
between groups.
Figure 4.9 Cycling performance as measured by the average power output (W) 
maintained during the 60 min time trial before (Pre) and after (Post) 3-week training 
intervention. † Significantly different from Pre (p<0.01). Values are mean ± SE; n = 7/group.
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4.4 Discussion
The novel findings of the present study were that in skeletal muscle of trained individuals 1) 
resting glycogen content, 2) the maximal activities of citrate synthase and β-hydroxyacl-CoA
dehydrogenase, 3) the content of the electron transport chain component cytochrome C oxidase 
subunit IV, and 4) rates of whole-body fat oxidation during submaximal exercise were enhanced 
to a greater extent by training twice every second day compared to training daily for 3 weeks. 
These findings are in direct contrast to the original research hypothesis of this study, namely that 
well-trained athletes would have maximised their training adaptation, and that further gains 
would be minimal, independent of whether they trained daily or twice every second day. 
Nevertheless, despite metabolic and enzymatic changes resulting in an enhanced training 
adaptation profile after twice every second day ‘low glycogen’ training, this study was unable to 
detect a clear advantage to endurance performance compared to when subjects undertook daily 
workouts with normal glycogen stores.  
The present investigation was undertaken to further examine the hypothesis that commencing 
exercise sessions with low muscle glycogen levels would result in a more pronounced training 
adaptation compared to training in a normal glycogen condition (Febbraio, et al., 2002; Hansen, 
et al., 2005). Accordingly, subjects performed either two exercise bouts on the same day (100 
min of submaximal cycling followed by 1-2 hr rest and then an intense interval training session) 
or the same training sessions separated by 24 hr. The former training protocol (training twice 
every second day) resulted in a marked decrease in muscle glycogen concentration after the first 
exercise session, such that subjects commenced the second bout of training with significantly 
lower muscle glycogen content than before the first session of the day (Figure 4.2). In contrast, 
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when subjects performed the prolonged cycling bout and had 24 hr recovery, they began the 
intense interval training bouts with normal glycogen stores (Figure 4.2). While the term ‘train 
low, compete high’ has been used to describe the twice every second day protocol (Hansen, et al., 
2005), a fact often overlooked is that subjects in that study (and the present investigation) only 
performed 50% of their training sessions with low muscle glycogen content.
The present study chose to incorporate high intensity interval training sessions in combination 
with prolonged, steady-state aerobic riding as competitive cyclists typically employ such 
workouts in their race preparation [for review see (Hawley and Stepto, 2001)]. Previous studies 
have consistently demonstrated substantial performance enhancements after just 3 weeks of HIT 
in already well trained athletes (Lindsay, et al., 1996; Stepto, et al., 1999; Westgarth-Taylor, et al., 
1997; Weston, et al., 1997). Furthermore, previous study has also shown that when subjects 
commence HIT sessions with normal glycogen levels (~450-500 μmol/g dry wt.), they deplete 
~50% of resting stores (Stepto, et al., 2001).  Hence, it was not surprised to observe that when 
subjects performed self-selected HIT sessions at maximal effort following 100 min of cycling, at 
a time when glycogen stores were already 50% reduced, relative power output (the percentage of 
PPO sustained for the 8 x 5 min work bouts) was significantly lower compared to when the same 
sessions were undertaken in the glycogen replete state (Figure 4.3). Of note was that while self-
selected maximal power output was significantly lower for the first 6 HIT sessions (i.e., the first 
two weeks of the training programme), during the last week of training there were no differences 
in average power output whether or not subjects commenced the workouts with low or normal 
glycogen stores (Figure 4.3). The subjects are believed to have produced maximal efforts for all 
HIT sessions. Indeed, in order to ensure compliance, attractive financial incentives were provided 
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to the subject from each training group who performed the most overall work (when work was 
corrected for PPO and BM).
Resting muscle glycogen stores are typically increased by 20-30% when untrained subjects 
complete short term (i.e. < 6 weeks) endurance training programmes [for review see Hargreaves 
(1997)]. Resting muscle glycogen levels in endurance-trained subjects are consistently elevated 
(i.e. 450-550 μmol/g dry wt.) above untrained individuals (Hawley, et al., 1997). Hence, a 
surprising finding in the present study was that training twice every second day resulted in a 
further increase in muscle glycogen stores (Figure 4.4). These results are in agreement with those 
of Hansen et al. (2005) who only found elevated resting muscle glycogen content after their 
‘train-low’ intervention. 
In order to determine whether the training adaptation could be amplified by training twice every 
second day, indirect markers of tricarboxylic acid cycle flux (citrate synthase), β oxidation (β-
HAD) and electron transport chain activity (cytochrome c oxidase subunits) were measured. The 
increase in the activity/content of these mitochondrial enzymes only reached statistical 
significance in the group that trained twice every second day (Figure 4.6). It may seem surprising 
that 3 weeks of training is sufficient to elevate maximal enzyme activities in already trained 
subjects. However, previous study has also observed increases in β-HAD activity after just 5 days 
of intense training incorporating two sessions of HIT in well-trained athletes ingesting a low-
carbohydrate, high-fat diet (Cameron-Smith, et al., 2003). The potential mechanism for the 
increased mitochondrial enzyme activity after training twice every second day is hard to define, 
and it is possible that exercising with low glycogen stores could promote training adaptations 
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through perturbation in homeostasis (i.e. increased systemic factors) and not directly through low 
glycogen availability per se (Baar and McGee, 2008). Although catecholamine levels were not 
measured during training in the present study, Hansen et al. (2005) have reported that the 
catecholamine response to exercise performed with low muscle glycogen levels are higher than 
when exercise undertaken with normal glycogen stores, demonstrating a higher stress response. 
In contrast to the increases in mitochondrial enzyme activities induced by the twice every second 
day training regimen, mitochondrial DNA content and PGC-1α protein content (Figure 4.8B) 
were unchanged in response to both training interventions. Mitochondrial DNA is a marker of 
mitochondrial volume and is increased in trained compared to untrained individuals (Puntschart, 
et al., 1995). Furthermore, mtDNA typically parallels increases in mitochondrial density, 
although not necessarily by the same magnitude as mitochondrial volume (Puntschart, et al., 
1995). Consequently the ~20% increases in maximal enzyme activity observed after training 
twice every second day could coincide with a small increase in mitochondrial volume that is not 
detectable through mtDNA analysis (Figure 4.7). PGC-1α plays a role in regulating the 
expression of genes encoding mitochondrial proteins in skeletal muscle (Hood, et al., 2006). 
Importantly, PGC-1α can also co-activate the transcription factor nuclear respiratory fator-1 to 
regulate a nuclear encoded protein (mitochondrial transcription factor A or Tfam) that controls 
mtDNA replication and transcription (Joseph, et al., 2006). Although no previous study has 
examined the effect of twice every second day training on PGC-1α protein content, Mortensen et 
al. (2007) have previously reported that this training regimen does not increase the mRNA 
expression of the PGC-1α family of transcriptional coactivators. While an acute bout of high 
intensity training increases PGC-1α content to a greater extent than low intensity exercise 
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(Terada, et al., 2005), and chronic short duration interval training elevates PGC-1α to the same 
extent as more traditional endurance workouts (Burgomaster, et al., 2008), it is unlikely that the 
changes in power output observed between the twice every second day and once-a-day interval 
training sessions were large enough to increase PCG-1α protein levels. In addition, PGC-1
content was measured, but not transcriptional co-activity, it cannot be ascertain as to whether or 
not completion of high intensity training in the LOW group transiently increased PGC-1
activity, thereby contributing to the changes in mitochondrial enzymes measured.
Analogous to PGC-1α, the AMPK has been shown to have important regulatory roles in both the 
responses to an acute bout of exercise and also chronic training adaptations [for review see 
Aschenbach et al. (2004)]. The AMPK is an important sensor of decreased energy charge in cells 
and subsequently acts to increase catabolic reactions and decrease anabolic reactions, one of 
which is the direct phosphorylation and subsequent increased transcriptional co-activity of PGC-
1α (Jager, et al., 2007). In this regard, Wojtaszewski et al. (2003) have previously reported that 
AMPK activity in resting human muscle and the degree of activation during an acute exercise 
bout are dependent on the fuel status of the muscle cells (i.e., AMPK activity is elevated in
muscle with low glycogen stores). In the present investigation AMPK phosphorylation and total 
AMPK protein content was similar before and after both training interventions (Figure 4.8A). 
Thus, the results of the present study indicates that the 3 week training programme (in which 
subjects performed 50% of their training sessions with low starting muscle glycogen content) was 
insufficient to increase AMPK protein levels and/or activation in already well-trained individuals. 
This finding is in agreement with Clark et al. (2004) who previously reported that 3 weeks of 
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intensified training in well-trained athletes does not alter AMPK signalling in skeletal muscle in 
response to a submaximal exercise bout.  
In order to assess the effect of the different training protocols on the metabolic responses to 
submaximal exercise, subjects performed 60 min of steady-state cycling pre- and post 
intervention. In accord with the elevated β-HAD activity after the twice every second day training 
programme, the present study also reported a robust increase in rates of whole-body fat oxidation 
compared to once-a-day training (Figure 4.5). Yet, despite creating metabolic conditions that 
should, in theory, enhance endurance capacity, training twice every second day failed to increase 
the performance of a 1 hour time-trial (a performance measure similar to road cycling time-trials 
conducted at major championships and Tours) undertaken after 1 hr of submaximal cycling, to a 
greater extent than one-a-day training. Previous studies (Burke, et al., 2000; Burke, et al., 2002; 
Carey, et al., 2001; Havemann, et al., 2006; Helge, 2000; Stellingwerff, et al., 2006) have also 
repeatedly demonstrated the ability of well-trained subjects to further improve their ability to 
oxidise fat and ‘spare’ carbohydrate after short-term (< 7 days) dietary/training periodisation. 
Part of the reason why nutrient/training interventions that enhance fat-oxidative capabilities do 
not confer concomitant performance benefits is that the observed ‘carbohydrate sparing’ is more 
likely to be an impairment of carbohydrate oxidation due to a down-regulation of the multi-
enzyme complex pyruvate dehydrogense (PDH) (Stellingwerff, et al., 2006).  Unfortunately, the 
muscle tissue in the present study was insufficient to assess PDH activity, but such a measure 
would provide useful mechanistic insight into training response/adaptation in future studies that 
manipulate the nutrient/training environment. 
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The finding of no difference in a whole-body endurance performance task contrasts that of 
Hansen et al. (2005) who reported that training twice every second day resulted in superior 
endurance capacity compared to training daily. Several major differences in the training protocols 
between the current study and that of Hansen et al. (2005) are likely to be responsible for the 
contrasting effects on performance. First, whole-body exercise (cycling) versus a one-legged 
kicking model was chosen as the training mode. Second, intense interval training sessions were 
incorporated into the 3 week training programmes. Third, subjects were allowed to self-select the 
highest sustainable power output during the HIT sessions, whereas Hansen et al. (2005)
‘clamped’ the training intensity. Fourth, athletes who had completed a base of aerobic training 
before entering the study were utilised, compared to previously healthy, but untrained subjects 
chosen by Hansen et al. (2005).  Notwithstanding such differences, one might offer an alternative 
perspective on the results from the present investigation. Namely, despite compromised high-
intensity training capacity, the twice every second day training regimen elicited a comparable 
increase in endurance performance to that attained after training every day. Thus for an athlete 
unable to train daily but who can perform two workouts in close proximity, with the second 
session performed under conditions of low starting muscle glycogen, ‘train-low’ may offer a time 
efficient method of maintaining training adaptations and performance.
In conclusion, compared to training daily, training twice every second day compromised high-
intensity training capacity but augmented selected markers of training adaptation (i.e., resting 
muscle glycogen content, the maximal activities of several mitochondrial enzymes and the 
protein content of COX IV). However, despite creating conditions that, in theory, should enhance 
endurance performance capacity, performance of a one hour time-trial undertaken after a 60 min 
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steady-state ride was similar after daily or twice every second day training. Further studies will 
be needed to determine whether low muscle glycogen stores per se or perturbation in systemic or 
other intramuscular factors are responsible for the amplified training response observed after 
twice every second day versus daily training schedules.
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Chapter Five
Acute signalling responses to intense endurance training
commenced with low or normal muscle glycogen
Adapted from: Yeo WK, McGee SL, Carey AL, Paton CD, Garnham AP, 
Hargreaves M, Hawley JA. (in preparation)
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5.1 Introduction
Substrate availability is a potent modulator of skeletal muscle training adaptation (Coyle, 2000; 
Hansen, et al., 2005; Hawley, et al., 2006). In the previous study described in Chapter 4, it was 
shown that well-trained endurance athletes who undertook a 3-wk training programme in which 
high-intensity interval training sessions were commenced with low muscle glycogen 
concentration increased selected markers of endurance training adaptation to a greater extent than 
athletes who began all training sessions with normal glycogen levels. These adaptations included 
an elevated resting muscle glycogen concentration, increases in the maximal activities of citrate
synthase and β-hydroxyacyl-CoA dehydrogenase and the total protein content of cytochrome c
oxidase subunit IV, and enhanced rates of whole-body fat-oxidation during submaximal exercise.
Chronic training adaptations are thought to be the result of the cumulative effects of repeated 
acute bouts of exercise (Hansen, et al., 2005; Hawley, et al., 2006; Pilegaard, et al., 2000; 
Widegren, et al., 2001). As such, one potential mechanism that might underlie the greater 
adaptation seen after training with low muscle glycogen availability is the acute myocellular 
stress associated with this state which may augment the activation of several protein kinases with 
roles in mitochondrial biogenesis. These include the AMPK (Steinberg, et al., 2006; 
Wojtaszewski, et al., 2003) and the p38 MAPK (Chan, et al., 2004). Accordingly, the purpose of 
the present study was to investigate the acute signalling responses to a single session of HIT 
undertaken with either low or normal muscle glycogen concentration. It was hypothesised that 
performing intense endurance exercise in the face of low muscle glycogen concentration would 
result in increased activation of AMPK and p38 MAPK and some of their downstream substrates. 
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5.2 Methods
5.2.1. Subjects and Preliminary Testing
Twelve endurance-trained male cyclists or triathletes volunteered to participate in this study. 
They gave their written consent after they were informed about the possible risks of all 
procedures. This study was approved by the RMIT University Human Research Ethics 
Committee. One week prior to the commencement of the study, each subject undertook an 
incremental cycling test to exhaustion on an electromagnetically braked cycle ergometer (Lode, 
Groningen, The Netherlands). The results from this test (peak O2 uptake and peak sustained 
power output) were then used to determine the power output corresponding to 70% of each 
subject’s VO2peak (63% of PPO) to be used in the subsequently described training sessions. The 
testing protocol (Hawley and Noakes, 1992) and the equipment used for this test have been 
described in detail in previous chapter in this thesis (Chapter 3). The maximal test and all 
experimental trials were conducted under standard laboratory condition (18-22ºC, 40-50% 
relative humidity) and subjects were fan cooled during all training sessions.
Table 5.1. Characteristics of the subjects that participated in the HIGH and LOW 
group. PPO, Peak sustained power output. Values are means ± SE; n = 6/group.
Age BM VO2peak VO2peak PPO
(yr) (kg) (L/min) (mL/kg/min) (W)
HIGH 29.8 ± 2.7 77.5 ± 4.8 4.7 ± 0.2 61.2 ± 1.4 370.1 ± 12.9
LOW 26.3 ± 2.9 77.1 ± 4.9 4.7 ± 0.2 61.9 ± 2.2 360.9 ± 10.0
110
5.2.2. Experimental Design
An overview of the experimental design is shown in Figure 5.1. In brief, the subjects were 
divided into two groups matched for age, VO2peak and training history. They then undertook two 
different laboratory training protocols according to the schedule of their respective groups. One 
group (HIGH) performed a 100-min steady state ride (AT) at ~70% VO2peak (63% of PPO) on the 
first day and high intensity interval training (HIT; 8 x 5-min work bouts at self selected maximal 
effort with 1-min recovery in between work bouts at  100W) 24 hr later. In contrast, the other 
group (LOW) performed both training sessions on the same day, performing the AT in the 
morning (0800 hr), followed by HIT after 1-2 hr of rest (Figure 5.1). During the time between 
these two training sessions, subjects in the LOW group rested in the lab and were given ad 
libitum access to water. The training sessions and equipment set up have been described in detail 
in previous chapter in this thesis (Chapter 4). All training sessions were performed in the 
laboratory under the supervision of the principal investigator and power output for all these 
sessions were recorded using PowerTap power meters (CycleOps). Skeletal muscle biopsies from 
the vastus lateralis were taken immediately before and after the HIT sessions (Figure 5.1). The 
muscle biopsy procedure has been explained in detail in previous chapters in this thesis (Chapters 
3 and 4). All muscle samples were rapidly frozen in liquid N2 within ~15 s and stored at -80ºC 
until further analysis.
5.2.3. Dietary and Training Control
Twenty four hr prior to all training sessions, subjects’ dietary intake were ‘clamped’ (0.21 MJ/kg 
BM; 8 g/kg/d and 65% of energy from CHO; 2.0 g/kg/d protein and 1.0 g/kg/d fat).  All meals 
and snacks were supplied with diets being individualized for food preferences and body mass 
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(BM). Subjects received their food in pre-prepared packages and were required to keep a food 
checklist to note their compliance with the dietary instructions and their intake of any additional 
food or drinks. Empty bags and containers were also brought back to the lab to confirm the 
consumption of the food prescribed. Subjects refrained from exercise the day prior to an 
experiment.
Figure 5.1 Overview of the study design and experimental trial. AT, Aerobic training.  
HIT, High intensity interval training. ↨, Muscle biopsy.
5.2.4. Analytical Procedures
Muscle Glycogen Concentration
Muscle glycogen concentration was analysed as described in previous chapters in this thesis
(Chapters 3 and 4). In brief, approximately 10-15 mg of muscle was freeze-dried and powdered 
with all visible blood and connective tissue removed under magnification. The freeze-dried 
100 min steady-state
@ 70% VO2peak (AT)
1-2 hr LOW
HIGH
100 min steady-state
@ 70% VO2peak (AT)
8 x 5 min @
maximal pace (HIT) 24 hr
24 hr dietary & 
training control
8 x 5 min @
maximal pace (HIT) 
24 hr dietary & 
training control
24 hr dietary & 
training control
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muscle sample was then extracted and glycogen concentration was determined via enzymatic 
analyses. 
Nuclear Fractionation and Whole Cell Extraction
Approximately 70-80 mg of wet muscle were cut and divided into two portions. The first portion 
(35-40 mg) of the wet muscle was homogenised in ice cold buffer A (250 mM sucrose, 10 mM 
Tris, pH 7.5, 10 mM NaCl, 3 mM MgCl2, 1 mM DTT, PIC [2 µL per 40 mg] and 1 mM PMSF) 
before being spun for 5 min at 500 x g at 4°C. The supernatant was removed and the pellets were 
then resuspended in ice cold buffer B (50 mM Tris, pH 7.5, 1 mM EDTA, 1 mM EGTA, 10% 
glycerol, 1% Triton X-100, PIC [2 µL per 40 mg], 50 mM NaF, 50 mM MgCl2, 1 mM DTT, 1 
mM PMSF and 5 mM Na pyrophosphate) for 10 min. The lysates were then spun again for 5 min 
at 3000 x g at 4ºC and the supernatant representing the nuclear fraction was aliquoted and stored 
at -80ºC until further analysis.
The second portion (35-40 mg) of wet muscle was homogenised (50 mM Tris HCl, pH 7.5, 1 mM 
EDTA, 1 mM EGTA, 1 mM dithiothreitol, 50 mM NaF, 5 mM Na pyrophosphate, 10% glycerol, 
1% Triton X-100, 10 µg/ml trypsin inhibitor, 2 µg/ml aprotinin, 1 mM benzamidine, and 1 mM 
phenylmethylsulfonyl fluoride) and centrifuged at 20,000 x g for 30 min at 4ºC.  The supernatant 
representing the whole cell lysates was aliquoted and stored at -80ºC until further analysis. Total 
protein concentration in both the nuclear and whole cell lysates were determined by the 
bicinchoninic acid method (Pierce, IL, USA).
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Western Blotting
Muscle lysates containing 60 g (p-AMPKThr172, total AMPK, p-p38 MAPKThr180/Tyr182, total p38 
MAPK, p-CAMKIIThr286, PGC-1α, α-tubulin) and 50 g (nuclear HDAC5, total HDAC5,  p-
CREBSer133 and p-ATF2Thr69/71) of total protein were electrophoresed on 10% (p-AMPKThr172, 
total AMPK, p-p38 MAPKThr180/Tyr182, total p38 MAPK, p-CAMKIIThr286, PGC-1α, α-tubulin) and 
5-14% (nuclear HDAC5, total HDAC5, p-CREBSer133 and p-ATF2Thr69/71) SDS-PAGE and 
detected by immunoblotting with antibodies specific for pAMPKThr172, total AMPK (gifts from 
Professor Bruce Kemp), p-p38Thr180/Tyr182 MAPK, total p38 MAPK, nuclear HDAC5, total 
HDAC5, p-CREBSer133, p-ATF2Thr69/71, p-CAMKIIThr286, α-tubulin (Cell Signalling, Danvers, MA)
and PGC-1 (Santa Cruz Biotechnology, Santa Cruz, CA; sc13067). An internal control 
(standardised human skeletal muscle sample) was used in all gels to account for variability 
between exposures of different membranes. The immunoreactive proteins were detected with 
enhanced chemiluminescence (GE Healthcare) on a BioRad Chemidoc XRS system (BioRad, CA) 
and quantified by densitometry (Quantity one, BioRad, CA). Phosphorylation of AMPKThr172 and 
p38Thr180/Tyr182 MAPK were expressed relative to their respective total protein concentrations
while p-CAMKIIThr286 and PGC-1α was expressed relative to standard control α-tubulin.
5.2.5. Statistical Analysis
Treatment effects were analysed using two-factor (treatment and time) repeated measure analysis 
of variance (ANOVA) with post-hoc analysis performed using the Holm-Sidak method. Data 
were analysed using SigmaStat 3.1.1 (Systat Software, Inc., CA) and all values are expressed as 
means ± standard error (SE), with significance reported as P < 0.05. 
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5.3 RESULTS
5.3.1 Muscle glycogen concentrations
Figure 5.2 displays muscle glycogen content before and after HIT session. There was no 
significant interaction between the two factors of treatment and time. There were significant main 
effects of both treatment and time on muscle glycogen content. As would be expected, muscle 
glycogen concentration was significantly higher in HIGH compared to LOW before the HIT (390 
± 28 vs. 256 ± 67µmol/g dry wt.). After HIT, glycogen levels were reduced significantly in both 
groups (P < 0.05) such that HIGH is significantly elevated compared with LOW (229 ± 29 vs. 
124 ± 41 µmol/g dry wt.; P < 0.05).
Figure 5.2 Muscle glycogen concentration before (Pre) and after (Post) high intensity 
interval training for groups that performed HIT with normal (HIGH) versus low (LOW) 
muscle glycogen concentration. #, Significantly different at P < 0.05. Values are mean ± SE; 
n ≥ 5/group.
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5.3.2 Self selected training intensity during HIT
Self-selected average power output during the HIT was significantly greater in HIGH compared 
with LOW (308 ± 14 vs. 270 ± 13 W, or 83 ± 2 vs. 75 ± 3% PPO; P < 0.05; Figure 5.3).
Figure 5.3 Self-selected average power output during the HIT session. #, Significantly 
higher than LOW. Values are mean ± SE; n = 6/group.
5.3.3 p-AMPKThr172 and p-p38 MAPKThr180/Tyr182
Figure 5.4A displays p-AMPKThr172 (relative to total AMPK) before and after HIT. There was no 
significant interaction between the two factors of treatment and time. There were significant main 
effects of treatment and time on p-AMPKThr172. p-AMPKThr172 was similar before the 
commencement of the HIT in both HIGH and LOW but increased significantly in both groups 
after HIT (HIGH, 3.5 ± 0.1 to 5.4 ± 0.5 vs. LOW, 3.8 ± 0.3 to 7.5 ± 1.1 arbitrary units; P < 0.05) 
such that the phosphorylation state was higher in LOW compared to HIGH (P < 0.05).   
Figure 5.4B displays p-p38Thr180/Tyr182 (relative to total p38 MAPK) before and after HIT.  There 
was no interaction between the two factors of treatment and time. Nor were there were any 
significant main effects for treatment and time on p-p38Thr180/Tyr182 (Figure 5.4B). 
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A
B
Figure 5.4 Phosphorylation of (A) AMPK at threonine 172 (p-AMPKThr172) and (B) p38 
MAPK before (Pre) and after (Post) high intensity interval training for groups that 
performed HIT with normal (HIGH) versus low (LOW) muscle glycogen concentration. # 
Significantly different at P < 0.05. Values are mean ± SE; n = 6/group.
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5.3.4 p-CAMKIIThr286 
Figure 5.5 displays p-CAMKIIThr286 (relative to α-tubulin) before and after HIT. There was no 
significant interaction between the two factors of treatment and time. There was significant main 
effect of time on p-CAMKIIThr286 (βm) but no significant main effect of treatment was observed. 
p-CAMKIIThr286 (βm) was similar before HIT in both groups but was only increased significantly 
in HIGH after the exercise bout (P <0.05; Figure 5.5). However, there were no significant main 
effects of treatment or time on p-CAMKIIThr286 (δ/γ) or when all 3 of the p-CAMKIIThr286
isoforms were quantified collectively. 
Figure 5.5 Phosphorylation of CAMKII (βm) at threonine 286 (p-CAMKIIThr286) before 
(Pre) and after (Post) high intensity interval training for groups that performed HIT with 
normal (HIGH) versus low (LOW) muscle glycogen concentration. #, Significantly different 
at P < 0.05. Values are mean ± SE; n = 6/group.
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5.3.5 HDAC5, p-CREBSer133and p-ATF2Thr69/71
There was no significant interaction between treatment and time. Neither were there any 
significant main effects of treatment nor time on total or nuclear HDAC5 (Figure 5.6A), p-
CREBSer133 (Figure 5.6B) and p-ATF2Thr69/71 (Figure 5.6C) in response to a single bout of HIT.
A     B
C
Figure 5.6 (A) Nuclear concentration of HDAC5, (B) Phosphorylation of cyclic AMP 
response element binding protein (p-CREB), and (C) Phosphorylation of activating 
transcription factor 2 (p-ATF2) before (Pre) and after (Post) high intensity interval training 
for groups that performed HIT with normal (HIGH) versus low (LOW) muscle glycogen 
concentration. Values are mean ± SE; n = 6/group.
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5.3.6 PGC-1α
There was no interaction between the two factors of treatment and time. Neither were there any 
significant main effects of treatment nor time on total PGC-1α protein expression with HIT 
(Figure 5.7).
Figure 5.7 Total PGC-1α protein expression before (Pre) and after (Post) high intensity 
interval training for groups that performed HIT with normal (HIGH) versus low (LOW) 
muscle glycogen concentration. Values are mean ± SE; n = 6/group.
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5.4 DISCUSSION
In the second experiment described in this thesis (Chapter four), it was reported that athletes who 
participated in a 3-wk training programme in which high intensity interval training sessions were 
commenced with low muscle glycogen concentration increased the maximal activities of several 
enzymes promoting endurance adaptations to a greater extent than athletes who began all training 
sessions with normal glycogen levels. As chronic training adaptations are thought to be the 
cumulative effects of repeated acute bouts of exercise (Hansen, et al., 2005; Hawley, et al., 2006), 
the present experiment sought to determine acute cell signalling responses to a single session of 
HIT commenced with either low- or normal muscle glycogen concentrations in an attempt to 
elucidate the potential mechanisms that might underlie the results observed in previous chapter in 
this thesis (Chapter 4). The main findings of the present study were that 1) AMPK 
phosphorylation was greater when HIT was commenced with low compared to normal muscle 
glycogen availability, and 2) despite the greater AMPK activation after intense interval training 
with low muscle glycogen availability, the localisation and phosphorylation state of selected 
downstream targets of AMPK (HDAC5, CREB) were unchanged.
AMPK is a member of a metabolite-sensing protein kinase family that functions as a metabolic 
'fuel gauge' in skeletal muscle. During exercise, AMPK becomes activated in response to changes 
in cellular energy status (e.g. increased adenosine monophosphate [AMP]/adenosine triphosphate 
[ATP] ratio) in an intensity-dependent manner and serves to inhibit ATP-consuming pathways, 
and activate pathways involved in carbohydrate and FA metabolism to restore ATP levels. 
AMPK may also be involved in the adaptive response of skeletal muscles to endurance exercise 
training [for review see (Reznick and Shulman, 2006)]. Previous reports, largely from muscle 
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biopsy studies in untrained humans, demonstrate that activation of AMPK during exercise occurs 
in an intensity- and duration-dependent manner: there is little or no increase in phosphorylation 
until the relative exercise intensity is > 50-60% of VO2peak, whereas AMPK becomes 
progressively more phosphorylated with exercise duration. For example, Fujii et al. (2000)
reported that AMPK activity was significantly increased in the vastus lateralis muscle following 
20 min of cycling at 70% but not at 50% VO2peak. With respect to exercise duration, AMPK 
activity increases during the first 5 min of moderate (60% of VO2peak) cycling with further rises 
observed after 30 min of exercise (Stephens, et al., 2002). AMPK becomes progressively more 
phosphorylated during prolonged (~210 min) low (45% VO2peak) intensity cycling exercise 
(Wojtaszewski, et al., 2002) with these responses more closely coupled to muscle glycogen
content than muscle AMP/ATP ratio.
In the current study, the HIT session was associated with a significant elevation of AMPK in all 
subjects, regardless of whether they commenced the session with low- or normal muscle 
glycogen levels (Figure 5.4A). However, AMPK phosphorylation was increased to a greater 
extent when HIT was commenced with low compared with normal muscle glycogen availability 
(Figure 5.4A). This greater AMPK activation occurred despite subjects attaining both higher 
absolute and relative power outputs when they commenced the HIT session with normal 
glycogen levels (Figure 5.3). In order to create conditions that are similar to previous study 
(Chapter 4), and to account for differences in the ability to train (i.e. relative intensity) with 
different levels of substrate availability, the subjects were deliberately instructed to cycle at their 
self-selected maximal effort during HIT sessions rather than ‘clamping’ the training intensity.
Wojtaszewski et al. (2003) have previously reported that AMPK activity in resting human muscle 
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and the degree of activation during subsequent cycling exercise are dependent on the fuel status 
of the muscle cells (i.e., AMPK activity is elevated in muscle low in glycogen). In support of the 
current results where AMPK was found to be activated to a greater extent when intense exercise 
was perform in the face of low muscle glycogen availability, McBride, et al., (2009) recently 
provided first evidence that glycogen binding to the glycogen-binding domain on the AMPK β 
subunit allosterically inhibits AMPK activity and phosphorylation by upstream kinases. More 
importantly, removal of the outer chains of glycogen by phosphorylase (such as during exercise), 
thus exposing outer branches, renders inhibition of AMPK more potent (McBride, et al., 2009). 
Taken collectively these observations strongly support the notion that glycogen content in 
skeletal muscle modulates the AMPK response to contraction and also highlight the interactive 
effects of exercise intensity and endogenous fuel availability in inducing training adaptations in 
well-trained athletes.
In an effort to determine whether the increased AMPK activation when subjects performed HIT 
in the face of low muscle glycogen availability might contribute to the differences in training 
adaptation observed previously (Chapter Four), several downstream targets of AMPK were 
assessed. AMPK has been reported to phosphorylate and inactivate HDAC5 (McGee, et al., 
2008b), which in turn leads to the removal of HDAC5 from the nucleus, allowing the myocyte 
enhancer factor 2 (MEF2) to bind and activate the PGC-1α promoter (Baar and McGee, 2008). In 
addition, PGC-1α is also known to have a CRE response element in its promoter region 
(Branvold, et al., 2008) while CREB has also been identified as the downstream target of AMPK 
(Thomson, et al., 2008). As such it was hypothesised that the increased in AMPK activation in
response to intense training with low glycogen availability would result in concomitant increases 
123
in the localisation and/or phosphorylation of some of these downstream targets of AMPK. This, 
however, was not the case: there were no differences in the localisation of HDAC5 and the 
phosphorylation state of CREB when subjects commenced intense exercise with either low or 
normal muscle glycogen levels (Figure 5.6). One explanation for these observations is that the 
magnitude of increase in AMPK phosphorylation was insufficient to specifically increase its 
activity towards HDAC5 and CREB. Alternatively, there may be other mechanisms by which 
chronic activation of AMPK increases mitochondrial enzyme activity, including but not limited 
to, AMPK effects on upstream stimulatory factor-1 (USF-1) (Irrcher, et al., 2008) and/or  PGC-
1α phosphorylation (Jager, et al., 2007) and/or localisation. Due to technical and muscle tissue
limitations, these downstream signalling pathways of AMPK were not able to be measured for
this thesis. Future studies should probably include alternative approaches (e.g. measurement of 
enzyme assays or mRNA expression) that may yield additional information regarding potential 
mechanisms by which AMPK exerts in effect on mitochondrial biogenesis. Nevertheless, total 
PGC-1α content was measured in the present study and was found to be unchanged by exercise in 
both groups (Figure 5.7). This result is in agreement with previous study in human subjects that 
reported PGC-1α was unchanged after 4 bouts of sprint cycling (Gibala, et. al.2009).  However, 
as PGC-1 protein content does not represent its transcriptional co-activity, it cannot be 
determined whether or not completion of high intensity training in the LOW group transiently 
increased PGC-1 activity, thereby contributing to the changes in mitochondrial enzymes 
observed in previous study (Chapter Four).
Nevertheless, the more pronounced increase in AMPK phosphorylation observed in the present 
study does provide a strong mechanistic link between performing intense endurance training in 
124
the face of low muscle glycogen availability and the subsequent increased in muscle glycogen 
storage capacity observed in previous study in Chapter 4, and others (Hansen, et al., 2005). In this 
regard, it is likely that the constant depletion of muscle glycogen during this nutrient-training 
strategy may have increased the body capacity to store muscle glycogen through higher AMPK 
phosphorylation. While the role of AMPK in mediating the adaptations in muscle glycogen 
storage capacity has not been directly proven in human, such phenomenon has been demonstrated 
consistently in animal studies (Barnes, et al., 2005; Holmes, et al., 1999).       
The MAPK signal transduction cascade has been identified as a candidate system that converts 
contraction-induced biochemical perturbations in skeletal muscle into appropriate intracellular 
responses. The MAPK pathways include the stress-activated protein kinase p38 MAPK, which 
has been reported to be involved in mediating skeletal muscle adaptive responses to endurance 
training (Akimoto, et al., 2005; Fan, et al., 2004). Despite the higher AMPK phosphorylation in 
subjects who commenced HIT with low muscle glycogen concentrations, the phosphorylation 
state of p38 MAPK was not different between groups before and after the HIT session (Figure 
5.4B). In contrast, Yu et al. (2003), have previously reported a significant increase in p38 MAPK 
after intense exercise in subjects similar to those recruited for the present investigation. 
Differences between results from the experiments of Yu et al. (2003) and the current study are 
hard to explain, although training intensity was ‘clamped’ in the former investigation and was 
markedly higher than the ‘self selected’ intensity chosen by the subjects in the present study. 
Furthermore, in that study Yu et al. (2003) observed a main effect for time (pre vs. post) but no 
interaction with training status. Not surprisingly given the lack of differences in p38 MAPK 
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signalling, the phosphorylation state of the selected downstream target of p38 MAPK (ATF2) 
was not different between groups (Figure 5.6C).
CaMKII has been implicated in skeletal muscle endurance training adaptation, with its degree of 
activation dependant on the prevailing exercise intensity (Chin, 2004; Rose, et al., 2006). In the 
present study, the phosphorylation state of the βm isoform of CaMKII was increased significantly 
only when the high intensity interval training was performed with normal muscle glycogen 
concentration (Figure 5.5). However, in contrast to a previous study by Rose et al. (2006) that 
reported an exercise effect on CaMKII-δ/γ isoform phosphorylation but not CaMKII-βm isoform, 
we were not able to detect any significant increase in the phosphorylation state of CaMKII-δ/γ 
isoform. Differences in results from the present investigation and that of Rose et al. (2006) may 
be related to the training status of the subjects and the absolute exercise intensities used in these 
studies. This increase in the phosphorylation of CaMKII-βm isoform is most likely due to the
differences in training power output between the two groups of subjects. Nevertheless, when all 
the three CAMKII isoforms were quantified collectively, there were no effects of either treatment 
or time on the phosphorylation state of CAMKII.  
The present study has focused on the early signalling responses to a single bout of HIT 
commenced with low- or normal muscle glycogen. While the findings in the present study 
strongly suggest that resting muscle substrate availability plays an important regulatory role in 
AMPK activation during subsequent exercise, one should not discount other factors as being 
important in modulating this response. For example catecholamine levels when exercise is 
undertaken with low muscle glycogen are higher than when the same intensity exercise is
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performed with normal muscle glycogen stores (Hansen, et al., 2005), demonstrating that a higher 
stress response is elicited when training is commenced with low glycogen availability. When 
several bouts of moderate to intense exercise (50-75% VO2 peak) are performed in succession, 
separated by 30-60 min of rest intervals, the secretion of growth hormone (Kaciuba-Uscilko et al., 
1992; Kanaley et al., 1997), catecholamines, glucagon (Marliss et al., 1991; Kaciuba-Uscilko et 
al., 1992) and cortisol (Kaciuba-Uscilko et al., 1992) are progressively increased. However, not 
all studies demonstrate this effect and Bremner et al. (1977) have reported similar catecholamine, 
growth hormone and cortisol responses during two 30 min bouts of exercise at 50% VO2 peak 
(Brenner et al., 1997). Ronsen et al. (2002) reported that plasma interleukin (IL)-6 and IL-1 
receptor antagonist (IL-1ra) responses were significantly elevated when a second bout of exercise 
was performed only after 3 hr of recovery, an effect the authors attributed to muscle glycogen 
depletion. Arterial plasma FFA concentrations are also markedly elevated during exercise and 
subsequent recovery in well-trained subjects who perform steady-state exercise with low 
glycogen levels (Wojtaszewski, et al., 2003). This latter finding may be particularly relevant as 
raising plasma FFA concentration in the absence of exercise has been shown to induce 
mitochondrial biogenesis in skeletal muscle (Garcia-Roves, et al., 2007). Clearly the interaction 
of muscle fuel stores and the concomitant hormonal milieu during and after exercise play major 
roles in modulating the training response and subsequent adaptation and this is an area for future 
research.
In summary, the present study shows that high intensity interval training resulted in a 
significant increase in the activation of AMPK, with the magnitude of this increase being 
greater when training was commenced with low compared to normal muscle glycogen 
127
availability. Despite the greater AMPK activation after intense exercise in the face of low 
muscle glycogen availability, the localisation and phosphorylation state of selected downstream 
targets of AMPK (HDAC5, CREB) were unchanged. Further studies are needed to identify the 
mechanisms responsible for the amplified training response observed when well-trained 
subjects commence intense cycling with low muscle glycogen availability.  
128
Chapter Six
Summary and Conclusions
129
Summary & Conclusions
The primary aim of the studies undertaken in this thesis was to enhance our understanding of 
how nutrient availability in skeletal muscle interacts with endurance exercise to modify skeletal 
muscle adaptation in already well-trained athletes. Nutrient levels were manipulated by two 
different strategies: first by prescribing a high-fat, low-CHO diet, and secondly by manipulating 
the athletes training schedule. The subsequent training adaptation was studied by examining 
changes in whole-body metabolism and enzymatic activities as well as changes to selected cell 
signalling pathways that are related to both nutrient availability and training stimuli.       
The first study (Chapter Three) employed a dietary periodisation model called “fat adaptation 
and CHO restoration” to investigate the mechanisms underlying shifts in substrate oxidation 
during exercise after such dietary intervention in well-trained athletes. Previous studies have 
shown that this dietary periodisation protocol enhances the ability to oxidise fat during 
submaximal exercise in well-trained athletes. As the multi-substrate enzyme AMPK has been 
implicated as the “metabolic sensor” in skeletal muscle, the hypothesis for this study was that
fat adaptation and CHO restoration would result in changes in skeletal muscle fuel storage 
profile, and that these changes in fuel storage profile and would activate AMPK to induce the 
subsequent changes in substrate metabolism during exercise.   
The first novel finding of this study was that fat adaptation and CHO restoration increased both 
lipid and CHO storage in skeletal muscle. It was discovered that resting AMPKα1 and –α2 
activity was elevated after FAT-adapt, while the phosphorylation states of AMPK’s
downstream target, ACC, tended to be higher at rest and was significantly higher after exercise 
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during FAT-adapt. These results provided the first evidence of the mechanisms by which this 
dietary periodisation strategy serves to enhance rates of fat oxidation in trained individuals. In 
addition, while previous studies have suggested a role of muscle glycogen in regulating AMPK 
activity, the results of this experiment sheds new light for a role of muscle lipid status as a
regulator of resting AMPK activity. The significant association observed between muscle TG 
levels and AMPKα2 activity provides valid support for this contention. In addition, a 
significant association between resting muscle glycogen concentration and basal AMPK α1
activity was also observed, further supporting the role of nutrient availability in modulating 
skeletal muscle training adaptation. Taken collectively, the results of this study suggest that fuel 
selection in skeletal muscle in response to exercise can be manipulated by diet and/or the 
interactive effects of diet and exercise training and such effects are mediated by AMPK.
Given the observed increased in resting AMPK activity after FAT-adapt, and that AMPK has 
been implicated in mediating mitochondrial biogenesis in response to exercise training, it 
seemed prudent to investigate if training in the face of low muscle glycogen availability would 
enhance training adaptation. Accordingly, the second study (Chapter Four) was undertaken to 
determine the effects of a cycle training programme in which selected training sessions were 
performed with low muscle glycogen content on training capacity and subsequent endurance 
performance, whole body substrate oxidation during submaximal exercise, and several 
mitochondrial enzymes and signalling proteins associated with enhanced endurance training 
adaptation in well-trained athletes. As well-trained athletes should already have maximised
their training adaptation, the hypothesis of this study was that training adaptations would be 
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minimal, irrespective of whether the subjects trained with low or normal of muscle glycogen
levels.
The major finding from this study was that when well-trained athletes undertook a 3 wk cycle 
training programme in which selected HIT sessions were performed with low muscle glycogen 
content, they were able to increase their capacity to oxidise fat while concomitantly increasing
resting muscle glycogen concentration. Furthermore, several mitochondrial enzymes and proteins 
associated with enhanced endurance training adaptation, such as CS, β-HAD and COXIV were 
increased only in subjects who commenced exercise with low muscle glycogen stores. 
Interestingly, these adaptations were achieved despite the fact that the athletes were training at a 
lower relative intensity compared to athletes that performed their HIT sessions with normal 
muscle glycogen concentrations. In this regard, it appears that nutrient availability and associated 
metabolic stress should be taken into consideration as one of the factors that contribute to the 
overall ‘training stimulus’, which originally proposed to comprise mainly the inputs from the 
intensity, duration and frequency of exercise. Indeed, the results of this study suggest that 
compared with training daily, training twice every second day compromised high-intensity 
training capacity but augmented selected markers of training adaptation. Nevertheless, despite 
creating conditions that, in theory, should have enhanced endurance performance capacity, 
performance of a 1-h time trial undertaken after a 60-min steady-state ride was similar after once 
daily or twice every second day training.
The third experiment undertaken in this thesis (Chapter Five) was undertaken to elucidate the 
potential mechanisms underlying the enhanced adaptations seen with performing selected 
training sessions with LOW muscle glycogen concentration. In this regard, AMPK has been 
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proposed as the ‘metabolic fuel sensor’ in skeletal muscle and is activated during metabolic 
stress. Chronic activation of AMPK has also been reported to lead to mitochondrial biogenesis 
and associated increase in mitochondrial enzymes and proteins. Several putative signalling
proteins such as HDAC5 and CREB have also been implicated as the downstream target of 
AMPK by which AMPK exerts its effects to induce mitochondrial biogenesis. p38 MAPK is 
another signalling protein that has been reported to be regulated by nutrient levels (i.e. low 
glycogen concentration) and has also been shown to play a role in mitochondrial biogenesis. 
Accordingly, the hypothesis of this study was performing intense endurance exercise in the face 
of low muscle glycogen concentration would result in higher of AMPK and p38 MAPK and 
some of their downstream substrates. 
For the first time it was shown that performing intense endurance exercise in the face of low 
muscle glycogen concentration resulted in higher activation of AMPK, suggesting that the 
favorable adaptations seen in the previous study (Chapter Four) were likely to be mediated by 
AMPK. However, in contrast to the original hypothesis, the activation of p38 MAPK and 
CaMKII (all isoforms), and the phosphorylation and localisation of AMPK downstream targets 
was unchanged, indicating that either the activation of AMPK in this study is not strong enough 
to exert its effects on its downstream target, or AMPK might have exert its effects by another
pathway/s.   
The results from the experiments undertaken for this thesis show that nutrient availability can 
affect training capacity and is a powerful modulator of subsequent metabolic and skeletal muscle 
adaptation. In addition, the results also provide novel insights into the mechanisms by which 
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nutrient availability interacts with endurance training to modulate whole-body metabolism and 
skeletal muscle adaptation. Perhaps, the more exciting prospect is the findings from this thesis 
indicate that there is a role for ‘dietary periodisation’ strategies to be utilised to enhanced training 
adaptation. Rather than having athletes ingest a high CHO diet all year long, nutrient availability 
may be modified to promote intended training adaptations. For example, during the general 
preparation phase where the training goal is to build an aerobic base (i.e. to develop metabolic 
capacity), dietary carbohydrate intake may be deliberately reduced and dietary fat intake 
increased to promote the desired training adaptations (i.e. mitochondrial biogenesis). The 
negative effect of such strategy on training capacity should not be an issue as training volume is 
generally more important than training intensity during this phase of training. However, as 
training intensity becomes progressively more important, dietary carbohydrate content should be 
increased and dietary fat content should be decreased accordingly. Nevertheless, the optimisation 
of training using nutrient availability is still far from established and there are several questions 
that should be addressed by future research. First, in regards to fat adaptation and CHO 
restoration, it is not clear if the increased AMPK activity observed can indeed lead to augmented 
mitochondrial biogenesis. Should this be possible, studies should also be designed to explore how 
best to fit these nutrient-training strategies into macro- and micro-cycles of endurance training 
programmes. In addition, clear mechanisms linking fat adaptation to suppression of glucose 
metabolism, such as glucose transport, oxidation and enzymes linked to glycogen synthesis and 
breakdown have been important missing pieces of puzzle that might partly explain the observed 
adaptive responses and can possible serve to further optimise the protocol. 
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In the context of training once daily versus twice every second day, an important question that 
remains to be addressed is if such a training strategy would also resulted in an inhibition of CHO 
metabolism pathways (i.e. pyruvate dehydrogenase). Future research should also investigate the 
role of catecholamine and free fatty acid levels in modulating AMPK activation when exercise is 
undertaken with low muscle glycogen stores. Moreover, should technology be made available 
and accessible, it would be appropriate to examine if AMPK can indeed directly phosphorylate 
the transcriptional co-activator PGC1α and/or the upstream stimulatory factor-1 to induce the 
adaptations associated with this training strategy. While the results from the experiments in this 
thesis suggested that performing intense training in the face of low muscle glycogen availability 
can enhance the skeletal muscle adaptations profile, it would be interesting to know how low the 
muscle glycogen concentration has to decline before the beneficial adaptation of such training 
strategy is offset by the compromised training capacity. 
In conclusion, the results from the experiments in this thesis provides novel information on the 
effects of nutrient availability and/or the interactive effects of nutrient and training on metabolism 
and skeletal muscle adaptation in well-trained athletes and the mechanisms associated with these 
adaptations. Continued discovery of the mechanism associated with the interactive effects of 
nutrient availability and exercise training should enable training programmes to be planned in a 
more scientific manner and the optimisation of training adaptations by manipulating nutrient 
availability may indeed be possible! 
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